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The vascular and the nervous system are responsible for oxygen, nutrient, and information transfer and
thereby constitute highly important communication systems in higher organisms. These functional similar-
ities are reflected at the anatomical, cellular, and molecular levels, where common developmental principles
and mutual crosstalks have evolved to coordinate their action. This resemblance of the two systems at
different levels of complexity has been termed the ‘‘neurovascular link.’’ Most of the evidence demonstrating
neurovascular interactions derives from studies outside the CNS and from the CNS tissue of the retina. How-
ever, little is known about the specific properties of the neurovascular link in the brain. Here, we focus on reg-
ulatory effects of molecules involved in the neurovascular link on angiogenesis in the periphery and in the
brain and distinguish between general and CNS-specific cues for angiogenesis. Moreover, we discuss the
emerging molecular interactions of these angiogenic cues with the VEGF-VEGFR-Delta-like ligand 4 (Dll4)-
Jagged-Notch pathway.Introduction
The Neurovascular Link
In 1543, the Belgian anatomist Andreas Vesalius (1514–1564)
was the first to describe the parallel organization and alignment
of arteries and nerves and thereby laid the early foundation to
the concept of the neurovascular link (Carmeliet and Tessier-
Lavigne, 2005).
From a functional perspective, both systems are important for
information transport over long distances: whereas the nervous
system processes electric signals to transfer information, the
vascular system establishes long-range communication via dis-
solved messenger molecules and by serving as pathway for
leukocyte trafficking (Nourshargh et al., 2010). The functionality
of both systems requires correct patterning and guidance of their
cellular and subcellular elements.
In 1890, the neuroscientist Ramon y Cajal described the
specialized cellular structure at the tip of the growing axon,
which he termed the ‘‘axonal growth cone’’ (Carmeliet and Tess-
ier-Lavigne, 2005; Lowery and Van Vactor, 2009). Nowadays, we
know that axonal growth cones extend fan-like lamellipodial and
long, finger-like filopodial protrusions that sense the local micro-environment for guidance cues (de Castro et al., 2007; Lowery
and Van Vactor, 2009) and thereby steer the growing axon (Fig-
ures 1A and 1C). Around 100 years later, vascular biologists
discovered that sprouting blood vessels are led by cells that
resemble these axonal growth cones in cellular appearance
and function, exhibiting similar lamellipodia and filopodia struc-
tures. These cells have been named ‘‘endothelial tip cells’’ and
are key structures in the pathfinding of developing, newly form-
ing blood vessels (Carmeliet and Tessier-Lavigne, 2005; Carme-
liet and Jain, 2011; Gerhardt et al., 2003; Marin-Padilla, 1985;
Potente et al., 2011) (Figures 1B and 1D).
At the subcellular level, both systems sense guidance cues us-
ing structures based on the actin cytoskeleton (lamellipodia and
filopodia) resulting in extension and retraction of these structures
and in directed movements of growing nerves and blood vessels
(Figures 1A–1D).
Axonal growthcones that steer growingaxonsconsist of a cen-
tral and a peripheral domain. Whereas the peripheral domain is
composed of the lamellipodia consisting of an actin meshwork
and filopodia consiting of F-actin bundles, the central domain
of a growth cone contains mainly microtubules with only fewNeuron 87, July 15, 2015 ª2015 Elsevier Inc. 271
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Figure 1. Cellular Similarities between the Neuronal Growth Cone and the Vascular Endothelial Tip Cell
At the forefront of growing axons and growing blood vessels, the axonal growth cone and the endothelial tip cell are specialized, ‘‘hand-like’’ structures that sense
environmental cues using lamellipodia and ‘‘finger-like’’ filopodia. Thereby, the growing axons and growing blood vessels are guided to their respective targets.
The tip cell is an own cellular entity of a multicellular sprouting blood vessel (consisting of other specialized endothelial cells, see below), whereas the axonal
growth cone is a specialized, subcellular structure of the extending neuron. Nevertheless, they are functional analogs, as common attractive and repulsive
guidance cues have been adopted by the nervous and the vascular system during evolution to guide these structures.
(A) The axonal growth cone at the leading edge of a growing axon is a specialized structure at the tip of an extending neuron, usually far away from its cell body.
Actin-based structures (brown) such as lamellipodia and filopodia are used to sense and integrate attractive (blue) and repulsive (red) guidance cues in the local
(legend continued on next page)
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sometimeseven into filopodia (Figure1A; LoweryandVanVactor,
2009). In comparison to axonal growth cones, the cytoskeletal
composition and organization of endothelial tip cells is less well
described. Beside the fact that endothelial tip cells have been
discovered 110 years later than axonal growth cones, this is
mainly due to technical limitations. For instance, the lack of spe-
cific endothelial tip cell markers and the inability to observe endo-
thelial tip cell behavior on flat surfaces (in contrast to axonal
growthcones) limit in vitro studiesonendothelial tip cells and their
cytoskeletal organization. However, F-actin structures have been
observed at the leading edge and in filopodia of endothelial tip
cells in vivo (Figure 1B; Fraccaroli et al., 2012; Phng et al., 2013).
Interestingly, recent years have seen the discovery of common
molecular cues that guide both endothelial tip cells and axonal
growth cones. First, the four axonal guidance molecule families,
Netrins, Semaphorins, Ephrins, and Slits, and their receptors
have been shown to not only steer growing axons but also guide
growing blood vessels via these specialized structures (Carme-
liet and Jain, 2011; Carmeliet and Tessier-Lavigne, 2005; Quae-
gebeur et al., 2011) (Figures 1A and 1B).
Subsequently, a number of axonal guidancemolecules like the
morphogens wingless-type proteins (Wnts), Sonic Hedgehog
(Shh), and BoneMorphogenetic Protein (BMP) have been shown
to exert similar repulsive and attractive functions on neuronal
growth cones (Charron and Tessier-Lavigne, 2007) and blood
vessel endothelial tip cells (Zacchigna et al., 2008), although a
direct function on tip cell guidance has not been demonstrated
(Quaegebeur et al., 2011).
In addition, classical angiogenic factors like VEGF-A, FGF-2
and vessel-derived factors like Endothelin-3 and Artemin and
its receptor GFRalpha3 can also direct neuronal development
(Honma et al., 2002; Quaegebeur et al., 2011; Zacchigna et al.,
2008). These molecules affecting both the vascular and the ner-
vous system(s) have in consequence been termed ‘‘angioneur-
ins’’ (Segura et al., 2009; Zacchigna et al., 2008). Moreover,
mutual crosstalk and co-patterning of the vascular and neuronal
system are also a result of direct cellular interactions: for
instance, sensory neurons and Schwann cells in the PNS provide
a template for the patterning of arteries but not veins during skin
development, while neuronal release of VEGF induces arterial
differentiation (Li et al., 2013). On the other hand, vessel-derived
cues such as Artemin and Endothelin-3 can guide growing axons
(Honma et al., 2002; Makita et al., 2008).
The behavior of endothelial tip cells and axonal growth cones
is also regulated by the interaction of guidance cues with thetissue microenvironment in order to guide the extending axon to its appropriate
described but are rare. The central domain of an axonal growth cone is rich in mic
filopodia.
(B) The endothelial tip cell is a specialized vascular endothelial cell type at the tip of
type. While tip cells migrate and sense the environment, the main function of sta
third vascular endothelial cell type, lining the border of functional, established
lamellipodia and filopodia sense attractive (pro-angiogenic; blue) and repulsive
Thereby, the extending blood vessel reaches its target, for example another dev
(green) in filopodia have not been detected so far.
(C) Visualization of an axonin-1+ axonal growth cone of a dissociated spinal cord
filopodial extensions emerging from the lamellipodia. The growth cone image is ta
(D) Visualization of an Isolectin B4 (IB4)+ endothelial tip cell (red) in the mouse
extensions emerging from the tip cell body. The scale bar represents 10 mm.extracellular matrix (ECM) or by direct interactions with the
ECM. For example, vascular morphogenesis is guided by the tis-
sue distribution of VEGF-A, which depends on its ability to bind
to the ECM (Gerhardt et al., 2003; Ruhrberg et al., 2002).
Although the heparin-binding domain of VEGF-A (responsible
for ECM binding) is not essential for vascular development, dele-
tion of this domain leads to changes in vascular patterning and
endothelial tip cell morphology (Ruhrberg et al., 2002). Interest-
ingly, the ECM can also mediate direct signaling responses on
growing vessels. For instance, the ECM regulates endothelial
tip cell selection—a process mediated by Dll4-Notch signaling
(see below)—via Laminin-Integrin signaling-induced expression
of Dll4 in endothelial cells (Estrach et al., 2011; Stenzel et al.,
2011). Moreover, recent findings describe the influence of
ECM stiffness on angiogenesis and VEGF-signaling (Mammoto
et al., 2009). Briefly, ECM elasticity regulates the activity of the
Rho inhibitor p190RhoGAP, which, in turn, modulates the bal-
ance between the two antagonistic transcription factors TFII-I
and GATA2. On soft and rigid ECM gels, p190RhoGAP activates
TFII-I and inhibits GATA2, which suppresses VEGFR2 transcrip-
tion and inhibits angiogenesis. On gels of intermediate ECM
stiffness, however, p190RhoGAP activates GATA2 and inhibits
TFII-I, thereby increasing VEGFR2 transcription and stimulating
angiogenesis (Figure 4B) (Mammoto et al., 2009). It remains
to be determined whether this mechanosensitive signaling
pathway also regulates the tip versus stalk cell discrimination.
Given that growth factors such as VEGF also regulate
p190RhoGAP activity (Mammoto et al., 2009), another intriguing
question is whether molecules of the neurovascular link such as
Netrins or Nogo-A also regulate this mechanosensitive pathway.
Finally, the mode of action of axon guidance cues similarly de-
pends on interactions with the ECM (Barros et al., 2011; Moore
et al., 2009).
Angiogenesis, the Tip Cell Concept and the
VEGF-VEGFR-Dll4-Jagged-Notch Pathway
During development, growing tissues and organs require
adequate vascularization and this can occur via different
mechanisms of blood vessel formation, namely vasculogenesis,
sprouting angiogenesis, and intussusception (Carmeliet and
Jain, 2011; Herbert and Stainier, 2011; Potente et al., 2011;
Quaegebeur et al., 2011; Weis and Cheresh, 2011).
The process of sprouting angiogenesis is an important mech-
anism of new vessel formation in most organs, during develop-
ment, but also in different pathological settings (Carmeliet and
Jain, 2011; Jain and Carmeliet, 2012; Potente et al., 2011).
When a new sprout forms from a pre-existing vessel, the sprouttarget, where it forms a synapse. Microtubuli (green) in filopodia have been
rotubuli whereas its peripheral domain comprises actin-based lamellipodia and
the newly forming blood vessel, followed by stalk cells, another specialized cell
lk cells is to proliferate and form the vascular lumen. Phalanx cells constitute a
blood vessels (not shown). The endothelial tip cell uses actin-based (brown)
(anti-angiogenic; red) guidance cues in the local tissue microenvironment.
eloping blood vessel constituting a fusion partner (anastomosis). Microtubuli
commissural neuron from an embryonic day 5 (E5) chick. Note the numerous
ken from Joset et al. (2011), with permission. The scale bar represents 10 mm.
forebrain cortex at postnatal day 8 (P8). Note the numerous IB4+ filopodial
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Figure 2. Embryonic and Postnatal CNS Vascularization
(A) Scheme of an embryonic mouse neural tube (top) and of a postnatal mouse brain (bottom). The transverse (embryonic neural tube) and coronal (postnatal
brain) cutting planes are indicated.
(B) Schematic representation of sprouting angiogenesis into the neural tube during mouse embryogenesis. The perineural vascular plexus (PNVP, red) is formed
by vasculogenesis from mesodermally derived angioblasts at around E8.5. Subsequently, at around E9.5 angiogenic sprouts invade the CNS parenchyma and
(legend continued on next page)
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with another vessel sprout in a process called anastomosis, and
subsequently establishes an extended network of perfused
vasculature (De Smet et al., 2009; Potente et al., 2011; Wacker
andGerhardt, 2011;Wa¨lchli et al., 2015). Behind the tip cell, stalk
cells proliferate, supporting the elongation of the growing blood
vessel and form a lumen (Carmeliet and Jain, 2011; Geudens and
Gerhardt, 2011; Potente et al., 2011; Quaegebeur et al., 2011;
Wacker and Gerhardt, 2011; Wa¨lchli et al., 2015) (Figure 1B).
Recent experimental data and computational modeling suggest
that endothelial tip and stalk cell specification is dynamically
regulated by a feedback loop between VEGF-VEGFR signaling
and the Dll4-Jagged-Notch pathway (Jakobsson et al., 2010).
Upon stimulation with VEGF-A, activated endothelial cells ex-
pressing VEGFR1, 2, and 3 as well as Neuropilin-1 (Nrp-1)
dynamically compete for the tip cell position by upregulating
Dll4 (Jakobsson et al., 2010). Dll4 activates Notch signaling in
adjacent stalk cells, which through transcriptional downregula-
tion of VEGFR2,3 and Nrp-1, and upregulation of VEGFR1,
restricts their ability to acquire the tip cell position (Blanco and
Gerhardt, 2013). Dll4-Notch signaling limits the number of
endothelial tip cells and tip cell filopodia, and blocking this
pathway leads to increased tip cell and filopodia numbers. In
addition to this feedback between tissue-induced activation
and cell-cell contact-dependent lateral inhibition, also blood-
born signals influence endothelial tip cell formation. BMP9 and
10, presumably provided by blood flow to the luminal endothelial
surface, activate Alk1 and downstream Smad1/5/8 signaling,
which converge on common transcriptional targets together
with Notch signaling to limit tip cell formation (Larrive´e et al.,
2012; Moya et al., 2012). Interference with this central pattern
generator of endothelial tip versus stalk cell specification funda-
mentally disturbs the angiogenic balance and vessel function in
health and disease by causing excessive numbers of tip cells
and tip cell filopodia (Blanco and Gerhardt, 2013; Geudens and
Gerhardt, 2011; Potente et al., 2011). This VEGF-VEGFR-Dll4-
Jagged-Notch pathway can additionally be modulated by extra-
cellular matrix interactions (Germain et al., 2010; Stenzel et al.,
2011) and other signaling cascades, e.g., involving molecules
of the neurovascular link (Mancuso et al., 2008; Potente et al.,
2011).migrate towards the ventricle, where pro-angiogenic factors such as VEGF-A and
cells guide the CNS-invading blood vessels using endothelial tip cell filopodia. T
(C) Schematic representation of a coronal section of a mouse brain during postn
cortex, corpus callosum, and the hippocampus (blood vessels only).
(D) Sprouting angiogenesis into the CNS parenchyma is regulated via a number o
cell filopodia: endothelial sprouts invading the CNS parenchyma from E9.5 onw
angiogenesis into the CNS is regulated by non-CNS-specific cues for angiogen
Plexin-D1, Slit2-Robo4, as well as by CNS-specific cues such as GPR124, Wnt7
(E and F) Postnatally (e.g., at P4/P8), CNS angiogenesis is highly dynamic and the
the forefront of vascular sprouts, endothelial tip cells guide the growing vessel, the
tip cells can be found in all cortical layers (I–VI) (E). Only fewmolecular cues are kno
postnatal retinal angiogenesis), for instance, Nogo-A. Angiogenic endothelial tip
corpus callosum at P8 (not shown). The boxed area is enlarged in (F).
(G) Immunofluorescent staining of IB4+ endothelial sprouts invading the CNS
endothelial tip cell with its filopodia. The scale bars represent 10 mm.
(H) Immunofluorescent staining of IB4+ blood vessels (red) and endothelial sprou
arrowheads (I and J) indicate tip cells that are highlighted on the right side (I and
(I and J) Two IB4+ endothelial tip cells (red) in themouse forebrain cortex at (P8). No
guidance cues. Cell nuclei (DAPI, blue). The scale bars represent 10 mm.CNS Angiogenesis, the Neurovascular Unit and the
Blood-Brain Barrier
These cellular and molecular processes involved in sprouting
angiogenesis are also crucial for the vascularization of the brain
tissue (Mancuso et al., 2008; Quaegebeur et al., 2011).
During mouse embryogenesis, the perineural vascular plexus
(PNVP) around the neural tube forms via vasculogenesis at em-
bryonic 8.5 (E8.5) and later gives rise to the arteries and veins of
the leptomeninges (pia mater and arachnoidea) (Figure 2B).
Experimental work with avian embryos showed that the forma-
tion of the PNVP depends on neural tube-derived VEGF-A
signaling through VEGFR2 expressed on angioblasts forming
the PNVP (Mancuso et al., 2008). Subsequently, at E9.5, endo-
thelial sprouts emanate from the PNVP and invade into the
CNS parenchyma, thereby forming the intraneural vascular
plexus (INVP) via sprouting angiogenesis (Daneman et al.,
2010) (Figures 2B–2D). The migration of endothelial cells into
the CNS parenchyma and toward the subventricular zone
(SVZ) is regulated by different signaling pathways. VEGF-A-
VEGFR-Neuropilin-1 signaling has a critical role for appropriate
vessel ingression and patterning and thus for the formation of
the INVP (Mackenzie and Ruhrberg, 2012). Whereas during
developmental stages neurons are the predominant source of
VEGF-A, glial cells become the predominant producers of
VEGF-A in the CNS once vascular remodeling is completed
around postnatal day (P) 24 (Mancuso et al., 2008). Accordingly,
ectopic overexpression of VEGF-A isoforms or the soluble
VEGF-A decoy receptor sFlt-1 resulted in aberrant vessel ingres-
sion and vascular patterning of the avian neural tube (Bautch and
James, 2009). Recent evidence shows that the Wnt ligands
Wnt7a and Wnt7b as well as the G protein-coupled receptor
GPR124 are also crucial for proper vessel ingression into the
CNS parenchyma and the formation of CNS-specific properties
of the INVP (Anderson et al., 2011; Cullen et al., 2011; Daneman
et al., 2009; Kuhnert et al., 2010; Stenman et al., 2008). Angio-
genic sprouting and vascular remodeling is further regulated by
VEGF-VEGFRs-Nrp-1, Dll4-Notch signaling, Angiopoietins-Tie
receptors, Integrin receptors, Wnts-Frizzled receptors TGFb
signaling, the axonal guidance ligand-receptor pair Slit2-
Robo4, as well as DR6/TROY receptors (Jeansson et al., 2011;
Mancuso et al., 2008; Stenzel et al., 2011; Tam et al., 2012).Wnts are produced. At the forefront of these angiogenic sprouts, endothelial tip
he boxed area is enlarged in (C).
atal development. Blood vessels (red) and nerves (green) are indicated in the
f attractive and repulsive molecular cues presumably acting on endothelial tip
ard grow along radial glia fibers towards the ventricle. Molecularly, sprouting
esis such as VEGF-A-VEGFR2/Neuropilin-1, Semaphorin-3A/Semaphorin-3E-
a/b-Frizzled6, and DR6/TROY.
complex vessel network is mainly established via sprouting angiogenesis (E). At
reby further expanding the vascular network (F). At, e.g., P4 and P8, endothelial
wn that regulate postnatal brain angiogenesis (in contrast to thewell-described
cells of growing blood vessels are also abundant in the hippocampus and the
tissue of the embryonic neural tube (hindbrain) at E8.5. The inset shows an
ts (arrowheads) in the postnatal cortex at P8. Cell nuclei (DAPI, blue). Labeled
J). The scale bar represents 200 mm.
te the numerous filopodial extensions exploring the local microenvironment for
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Figure 3. The Neurovascular Unit and the Blood-Brain Barrier
(A) Scheme of the neurovascular unit (NVU) for a newly forming vascular sprout showing involved perivascular cell types such as astrocytes, pericytes, and
neurons. An endothelial tip cell guides the sprout throughout the tissue, followed by endothelial stalk cells. Phalanx cells are quiescent endothelial cells still
capable of sensing angiogenic stimuli. At the level of the endothelial tip cell, the basal lamina is not (fully) established. The perivascular stem cell niche in the
subventricular zone (SVZ) including ependymal cells, neuronal stem cells, and endothelial cells is shown as well. Cutting planes for (D) and (E) are indicated.
(B and D) Scheme of the NVU for established blood vessels that is composed of a variety of cell types including endothelial cells, pericytes, astrocytes, and
neurons. Transverse (B) and longitudinal (D) sections of the scheme in (A) are shown. Endothelial cells and pericytes are ensheathed by a common basal lamina,
the endothelial basement membrane (composed of the endothelial and the parenchymal basement membrane). The blood-brain barrier (BBB) is formed by
microvascular endothelial cells that are connected via complex tight junctions (TJ), thereby inhibiting paracellular diffusion of watersoluble molecules. The
endothelial cells regulating the transport of molecules between the blood and the brain parenchyma via the expression of influx and efflux transporters.
(C) An IB4+ endothelial tip cell (red) in the mouse forebrain cortex at P8. The vascular endothelial tip cell extends numerous, finger-like filopodial extensions that
explore the local microenvironment for guidance cues. GFAP+ astrocytes and GFAP+ radial glia (green), cell nuclei (DAPI, blue). The scale bar represents 10 mm.
(legend continued on next page)
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expanded via sprouting angiogenesis (Figures 2E–2I) (Wa¨lchli
et al., 2015). Only few molecular cues besides VEGF-A (Ogun-
shola et al., 2000) are currently known to regulate postnatal
vascular patterning. One recently identified example is, for
instance, the axonal growth inhibitor Nogo-A (Wa¨lchli et al.,
2013). How these signaling pathways interact among each other
andwith the VEGF-VEGFR-Dll4-Jagged-Notch pathway to regu-
late brain angiogenesis is only poorly understood (Eichmann and
Thomas, 2013; Mancuso et al., 2008).
At the cellular level, endothelial cells invading the CNS interact
with cells of the surrounding CNS-parenchyma, including neu-
rons, astrocytes, pericytes, postnatally also oligodendrocytes,
as well as neural stem cells (Eichmann and Thomas, 2013; Man-
cuso et al., 2008; Quaegebeur et al., 2011) (Figures 3A–3F).
Neurons, astrocytes, pericytes, and endothelial cells form the
neurovascular unit (NVU) (Figures 3A–3E) are functionally
coupled to regulate cerebrovascular interactions and contribute
to the regulation of CNS angiogenesis (Eichmann and Thomas,
2013; Mancuso et al., 2008; Quaegebeur et al., 2011).
The importance of the interactions between the nervous and
the vascular system was first illustrated by the early observation
that the CNS parenchyme provides instructive signals that regu-
late endothelial cell sprouting into the CNS and simultaneously
induce CNS-specific properties in endothelial cells (Stewart
and Wiley, 1981; Tam and Watts, 2010). These specific proper-
ties of CNS blood vessels are, for instance, represented by the
formation of the blood-brain barrier (BBB), the best-studied
feature distinguishing CNS capillaries from vessels outside the
CNS (Zlokovic, 2008) (Figures 3D–3G). The particular barrier
properties of the endothelial cells forming the BBB are estab-
lished during development, mainly by extrinsic cues provided
by the CNS microenvironment (Stewart and Wiley, 1981; Tam
and Watts, 2010). Properties intrinsic to the CNS endothelium
have been proposed (Vasudevan et al., 2008) but a functional
role during barriergenesis is unknown. The BBB comprises
of complex tight junctions (Zlokovic, 2008) (Figures 3D–3G)
and associated selective transport mechanisms to form a
regulated physical permeability barrier that can become leaky
in CNS pathologies (Storkebaum et al., 2011; Zlokovic, 2008,
2011). Interestingly, at certain sites in the CNS such as the
SVZ, these barrier properties can locally be modified (Tavazoie
et al., 2008).
Similar to the blood-brain barrier, the retina forms a highly
sophisticated interface between the retinal tissue and the blood
vascular system, called the blood-retina barrier (Runkle and
Antonetti, 2011). The retina constitutes a part of the CNS that
is vascularized postnatally, therefore allowing easy access.
The relatively simple and flat geometry of the retinal tissue and
its vascularization via the initial radial growth of blood vessels
facilitates visualization of sprouting angiogenesis. Therefore,(E) Established vessel in the adult mouse cortex displaying blood-brain barrier ch
endothelial cells (red). VE-cadherin+ cell-cell junctions (green). The scale bar rep
(F) IB4+ endothelial tip cell (red) and PDGFRb+ pericytes (white) in the mouse for
(G) Cultured mouse brain microvascular endothelial cells stained for the tigh
represents 10 mm.
(H) Electronic microscopy picture of the blood-brain barrier in the adult mouse br
scale bar represents 10 mm.the retina is a commonly used model to study effects on sprout-
ing angiogenesis and endothelial tip cell behavior (Pitulescu
et al., 2010; Sawamiphak et al., 2010a). Other regions of the
CNS such as the cortex, hindbrain, and even the spinal cord
have a more complex three-dimensional structure that compli-
cates a comprehensive description of vascular patterning.
However, the emerging concept of organ- and region-specific
mechanisms of angiogenesis (see below) highlights the impor-
tance of studying these brain tissues in more detail. Table 1
summarizes the methods currently available to study angiogen-
esis and barriergenesis in the CNS (brain, spinal cord, and retina)
(Table 1).
In light of the importance of CNS tissue-derived signals for the
differentiation of the brain endothelium and given that the role
of common guidance cues on angiogenesis has been well
described outside the CNS and in the CNS tissue of the retina
(Carmeliet and Tessier-Lavigne, 2005; Eichmann and Thomas,
2013) but not in the brain, we aimed to review the effects of mol-
ecules involved in the neurovascular link on brain angiogenesis
as compared to peripheral tissues.
Recent reviews have focused on the roles of all four of the clas-
sical families of axon guidance cues in angiogenesis (Eichmann
and Thomas, 2013; Quaegebeur et al., 2011). Here, we first
discuss two typical examples, namely Netrins and Semaphorins,
and the Nogo family of proteins, before highlighting recent evi-
dence on CNS-specific angiogenic cues. We further describe
possible effects of these cues on blood-brain barrier formation
and try to understand how these molecules can be integrated
into the current concept of the neurovascular link. A special
focus will be on molecular crosstalks of these angiogenic cues
with VEGF-related pathways. We emphasize developmental
processes but provide also occasional examples on neurovas-
cular crosstalks in pathological conditions such as tumors and
ischemic conditions.
General Mechanisms of Angiogenesis
Netrins and Their Receptors in Angiogenesis
Netrin-1. Netrin-1 signaling in angiogenesis and vascular guid-
ance is facilitated by its interaction with the receptor Unc5b ex-
pressed on endothelial cells (Castets andMehlen, 2010; Lu et al.,
2004), which regulates angiogenesis in peripheral tissues as well
as the CNS (Figure 4A; Table S1). In the zebrafish embryo,
Netrin-1a is highly expressed in the ventral neural tube and the
muscle pioneer cells at the horizontal myoseptum (HMS),
revealing no major expression differences between CNS and
non-CNS tissues (Lim et al., 2011; Wilson et al., 2006). At the
functional level, morpholino-mediated knockdown of Unc5b or
Netrin1a caused increased vessel branching of intersomitic
(and thus non-CNS) vessels (ISVs) and caused guidance defects
leading to aberrant ISV pathfinding (Lu et al., 2004), whereas
knockdown effects on CNS vessels were not investigated.aracteristics: Claudin5+ (yellow) tight junctions connecting neighboring CD31+
resents 10 mm.
ebrain cortex at P8. Cell nuclei (DAPI, blue). The scale bar represents 10 mm.
t junction-marker occludin (green). Cell nuclei (DAPI, blue). The scale bar
ain cortex. Note the tight junctions between neighboring endothelial cells. The
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Table 1. Methods to Address/Investigate Angiogenesis in the CNS
System Method Angiogenesis Barriergenesis References
Developmental Brain and Spinal Cord Angiogenesis
Developmental brain and spinal
cord angiogenesis
Embryonic mouse hindbrain
angiogenesis
Yes Yes Fantin et al. (2013a, 2013b);
Wa¨lchli et al. (2015)
Developmental brain angiogenesis Postnatal mouse brain
angiogenesis
Yes Yes Harb et al. (2013); Wa¨lchli et al.
(2013); Whiteus et al. (2014)
Developmental CNS (brain) and
non-CNS angiogenesis
Embryonic zebrafish
angiogenesis
Yes Yes Bussmann et al. (2011); Ellertsdo´ttir
et al. (2010); Lenard et al. (2013);
Tam et al. (2012)
Developmental brain and spinal
cord angiogenesis
Postnatal mouse brain
angiogenesis (tracer injections,
e.g., Evans blue, sulfo-NHS-
biotin)
No? Yes e.g., Wang et al. (2012)
Developmental Retinal Angiogenesis CNS: RETINA
Developmental retinal angiogenesis Postnatal retina angiogenesis Yes Yes Pitulescu et al. (2010); Sawamiphak
et al. (2010a)
Developmental retinal angiogenesis Postnatal retina angiogenesis—
Miles assay
No? Yes e.g., Koch et al. (2011)
Developmental retinal angiogenesis Postnatal retina angiogenesis Yes Yes Gerhardt et al. (2003)
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blood vessel endothelial cells at different developmental time
points (E10.5–E12.5) of both CNS and non-CNS tissues (Lu
et al., 2004), including endothelial cells of the intersomitic arteries
(Larrive´e et al., 2007), aswell as CNS endothelial cells of the INVP
and intra-ocular vasculature (Lu et al., 2004). Interestingly,
Unc5b is preferentially expressed on arteries (not veins) and
also found on endothelial tip cells of the retina at P4 (Lu et al.,
2004) (Figure 4A). In developing embryos of chick and quail,
Unc5b is highly expressed on INVP endothelial cells and endo-
thelial cells of vessels invading the limb bud, thereby displaying
expression in CNS and peripheral blood vessels (Bouvre´e et al.,
2008). Similar to the situation in the mouse (Larrive´e et al., 2007;
Lu et al., 2004), Unc5b is predominantly expressed on arterial
endothelial cells (Bouvre´e et al., 2008) and downregulated in
CNS and non-CNS vessels at later embryonic stages (E10–E13
CAM), when vessels acquire a quiescent state (Larrive´e et al.,
2007), further supporting Unc5b’s role in restricting sprouting
angiogenesis.
Genetic deletion of Unc5b leads to an increase in vessel
branching and endothelial tip cell and filopodia number in the
embryonic (E10.5/E12.5) mouse CNS (hindbrain, neural tube)
as well as in non-CNS blood vessels like the internal carotid
artery and the ISVs (at E10.5) (Lu et al., 2004). Moreover, intraoc-
ular injections of recombinant Netrin-1 induces retraction of
endothelial tip cell filopodia and reduces the number of endothe-
lial tip cells as well as the number of filopodia per tip cell in the
mouse retina at P5 and in the mouse hindbrain at E10.5 (Larrive´e
et al., 2007; Lu et al., 2004). Netrin-1-Unc5b signalingmainly acts
on sprouting angiogenesis and vessel branching in- and outside
the CNS (Larrive´e et al., 2007; Lu et al., 2004), as Netrin-1 does
not regulate vasculogenesis (Bouvre´e et al., 2008) and Unc5B
mutants (Lu et al., 2004) show no effects on arterio-venous spec-
ification. Whether Netrin-1-Unc5b signaling interacts with VEGF-
A-VEGFR2 signaling to regulate PNVP and INVP formation in the278 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.developing neural tube and brain remains unanswered. The rela-
tive normal appearance of the INVP in Unc5b mutant mice (Lu
et al., 2004) suggests that Unc5b might modulate vascular
patterning in the CNS without affecting the initial vessel ingres-
sion into the nervous tissue.
Molecularly, recent evidence suggests an interaction of Unc5b
signaling with the VEGF-VEGFR2 signaling pathway (Koch et al.,
2011) (Figure 4B; Table 2; Table S1). Koch and colleagues iden-
tified an interaction between Unc5b and Robo4, a vascular-spe-
cific receptor for Slit2 (Carmeliet and Tessier-Lavigne, 2005;
Jones et al., 2008, 2009; Koch et al., 2011). Robo4-Unc5b
binding and subsequent Unc5b signaling counteracts VEGF-
VEGFR2 signaling via competition for Src protein recruitment—
a downstream target of the VEGF-VEGFR2 signaling pathway
(Koch et al., 2011) (Figure 4B). Accordingly, Unc5b could nega-
tively regulate angiogenesis via direct regulation of VEGF
signaling in vitro, but the relevance of these findings for angio-
genesis in vivo is currently unclear. Whether Netrin-1-Unc5b
signaling regulates angiogenesis via modulation of the VEGF
pathway in different tissues in- and outside the CNS remains
an open question.
Interestingly, the embryonic expression pattern (Lu et al.,
2004) of Unc5b (on arteries and sprouting capillaries but not on
veins) is recapitulated in pathological angiogenesis models
such as oxygen-induced retinopathy (OIR) at P17 and subcu-
taneous tumor angiogenesis, exerting anti-angiogenic functions
(Larrive´e et al., 2007).
In addition to the anti-angiogenic roles of Netrin-1-Unc5b
signaling (Bouvre´e et al., 2008; Larrive´e et al., 2007; Lu et al.,
2004), several reports propose a contrasting pro-angiogenic
role for Netrin-1 (Castets and Mehlen, 2010; Park et al., 2004;
Wilson et al., 2006). For instance, Park and colleagues
described that Netrin-1 induces angiogenesis in the chick
chorioallantoic membrane (CAM) as well as in a mouse corneal
micropocket assay in vivo, where it acts synergistically with
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et al., 2004), Li and colleagues found that Unc5b/ mice
show no vascular patterning- and angiogenesis defects in-and
outside the CNS at E10.5–E11.5 (Wilson et al., 2006). Interest-
ingly, however, Netrin-1-Unc5b signaling exerts vascular bed-
specifc effects on angiogenesis in mouse and zebrafish, as
placental anigogenesis in Unc5b mutant mice and parachordal
vessels (PAVs) development in Netrin1a- and Unc5b morphant
zebrafish is impaired (Navankasattusas et al., 2008; Wilson
et al., 2006). Moreover, Netrin1a is involved in co-patterning of
vessels and nerves as it regulates patterning of motoneuron
axons which is important for normal PAV sprouting (Lim et al.,
2011).
Neuro-vascular interactions at the functional level were
observed in diabetic mice where Netrin-1 and Netrin-4 increased
capillary density of the vasa nervosa, leading to increased motor
and sensory nerve conduction velocities (Wilson et al., 2006).
In vitro, Netrin-1 andNetrin-4 promote tube formation, prolifer-
ation, and migration of peripheral endothelial cells such as
HUVECs and HUAECs but since none of the known Netrin-1 re-
ceptors (DCC, Unc5a-d, Neogenin, Adenosin2b [A2b]) could be
detected in these endothelial cells, Wilson et al. suggested that
Netrin’s proangiogenic effects are mediated via yet unidentified
Netrin receptors (Wilson et al., 2006).
Taken together, Netrin-1 has the capacity to act—similar to its
function in axonal guidance—as a bifunctional guidance cue in
the vascular system: repulsion via endothelial Unc5b (Larrive´e
et al., 2007; Lu et al., 2004), attraction via yet unknown receptors
on endothelial cells (Castets and Mehlen, 2010; Wilson et al.,
2006). Unc5b is preferentially expressed on arteries and capillary
endothelial tip cells and Netrin-1-Unc5b signaling mostly re-
stricts sprouting angiogenesis, tip cell filopodia extension, and
vessel branching during development in-and outside the CNS
(Larrive´e et al., 2007; Lu et al., 2004).
The debate about these contradicting reports on the negative
and positive regulation of angiogenesis by Netrin-1 is still
ongoing (Castets and Mehlen, 2010; Larrieu-Lahargue et al.,
2012), but neither the anti- nor the pro-angiogenic roles of
Netrin-1 or Netrin-4 have shown CNS specificity (Navankasattu-
sas et al., 2008; Wilson et al., 2006) (Table 3; Table S1).
Netrin-4. Netrin-4 can either act as an anti-angiogenic mole-
cule through binding to Neogenin-Unc5B and negative regula-
tion of VEGF signaling (Lejmi et al., 2008) or as a pro-angiogenic
molecule in the lymphatic system via regulation of integrin func-
tion (Larrieu-Lahargue et al., 2010) (Figure 4A; Table S1). In the
developing zebrafish, Netrin-4 is expressed in blood vessel
endothelial cells of the trunk, e.g., ISVs, and in CNS-blood vessel
endothelial cells of the brain, retina, and eye, as well as in neu-
rons of certain fiber tracts (Lambert et al., 2012). Functionally,
morpholino-mediated knockdown of Netrin-4 leads to severe
defects in non-CNS vessels (lack of ISV outgrowth), as well as
of the cranial vasculature, suggesting that the pro-angiogenic
effect of Netrin-4 is not tissue specific regarding the CNS versus
non-CNS domains (Lambert et al., 2012). In the mouse, Netrin-4
is broadly expressed at embryonic (E11.5–E18.5), postnatal
(P20), and adult stages, including various regions of the CNS
(brain, spinal cord) and the periphery such as pancreas, kidney,
intestine, and thymus (Yin et al., 2000).In vitro, Netrin-4 acts as pro-angiogenic stimulus to regulate
survival, proliferation, migration, tube formation, and sprouting
angiogenesis of non-CNS endothelial cells (HUVECs and
HUAECs) (Lambert et al., 2012). Interestingly, these effects are
mediated via phosphorylation of the protein kinases FAK, Akt,
JNK1/2, and ERK1/2 in HUVECs (Lambert et al., 2012), which
are common downstream targets of VEGF-VEGFR2 signaling,
therefore suggesting a crosstalk between the Netrin-4 and these
VEGF-A related pathways (Figure 4B; Table 2).
Netrin-4 has described pro-angiogenic roles also in angiogen-
esis of CNS pathologies, for instance, in a mouse model of cere-
bral ischemia (Hoang et al., 2009).
In contrast to these pro-angiogenic effects, others have found
anti-angiogenic roles for Netrin-4. Netrin-4 inhibits VEGF-
induced HUAEC (but not HUVEC) migration, tube formation,
and branching in vitro (Lejmi et al., 2008), likely mediated via
binding of Netrin-4 to Neogenin and recruitment of Unc5b
(Figures 4A and 4B). Mechanistically, Netrin-4 increases the
interaction between Unc5b and Neogenin in VEGF-stimulated
(or FGF-2-stimulated) HUAECs and Netrin-4 signaling exerts
its anti-angiogenic effects via inhibition of VEGF-induced
FAK-phosphorylation in HUAECs (Lejmi et al., 2008) (Figure 4B;
Table 2). This mechanism might also be at work in pathological
angiogenesis, as Netrin-4 overexpression reduced VEGF- and
FGF2-induced tumor angiogenesis in a subcutaneous xenograft
tumor model in vivo (Lejmi et al., 2008). Therefore, it will be inter-
esting to investigate whether Netrin-4 and VEGF signaling cross-
talk to exert pro-angiogenic effects on neo-angiogenesis in CNS
pathologies, e.g., in brain tumors.
In summary, Netrin-1 and Netrin-4 and their receptors act as
repulsive or attractive cues—partially via regulation of VEGF
signaling (Koch et al., 2011; Lejmi et al., 2008)—in developmental
angiogenesis in- and outside the CNS.
Semaphorins and Their Receptors in Angiogenesis
Semaphorins signal via Plexin receptors to regulate angiogen-
esis (Figure 4A), while a functional interaction with the Neuropi-
lin-1 (Nrp-1) receptor in angiogenesis has not been convincingly
established (see discussion below). In accordance with their
inhibitory roles in axonal guidance (Dickson, 2002), Semaphorins
usually inhibit angiogenesis (Figure 4B), although some family
members can be stimulatory (Capparuccia and Tamagnone,
2009). Here, we will mainly focus on class 3 Semaphorins as
they are the best-described Semaphorins in developmental
angiogenesis.
Semaphorin-3A. Semaphorin-3A and its receptor Plexin-D1
negatively regulate angiogenesis in zebrafish through modula-
tion of VEGF signaling (Figures 4A and 4B; Table S2). The
role of Semaphorin-3A in mouse angiogenesis is controversial
(Figure 4A; Table S2).
In the developing zebrafish, Semaphorin-3A1 and -3A2 are
expressed in the somites but absent from intersomitic bound-
aries containing ISVs, whereas the Semaphorin receptor
Plexin-D1 is specifically expressed throughout the zebrafish
vasculature including ISVs (Torres-Va´zquez et al., 2004). Sema-
phorin-3A1/Semaphorin-3A2 and Plexin-D1 morphants, as well
as the Plexin-D1 mutant out of bounds (obd) display vascular
patterning defects of ISVs: while ISVs usually grow between
somite blocks, ISVs of morphants and obdmutants do not followNeuron 87, July 15, 2015 ª2015 Elsevier Inc. 279
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Figure 4. General- and CNS-Specific Mechanisms of Angiogenesis and Endothelial Tip Cell Guidance
(A) Molecules of the neurovascular link and their receptors implicated in general- and CNS-specific mechanisms of developmental angiogenesis. Receptors in
both categories are expressed on endothelial tip cell (filopodia) as well as on endothelial stalk cells. Most of these receptors are expressed on both endothelial tip
(legend continued on next page)
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Table 2. Molecular Interactions with the VEGF-VEGFR2 Signaling Pathway
Ligand-Receptor Pair Ligand-Receptor Level Signaling (Protein) Level Transcriptional (mRNA) Level
Ligand-Receptor Pairs with Global Functions in Angiogenesis and Vascular Patterning
VEGF-A-VEGFR2 Plexin-D1[ (Kim et al., 2011), Netrin-4,
Neogenin, Unc5b[ (Lejmi et al., 2008)
Unc5b-Robo4 ? Src (recruitment) (Koch et al.,
2011)
Netrin-1-Unc5b ? ? ?
Netrin-4-UR ? Erk, Akt, JNK (Lambert et al.,
2012)
Netrin-4-Neo/Unc5b ? FAK (Lejmi et al., 2008) ?
Sema3A-Plexin-D1 Integrin (Serini et al., 2003) sFlt expression[ (Zygmunt et al., 2011)
Sema3E-Plexin-D1 ? RhoJ (Fukushima et al., 2011) Dll4 expressionY (Kim et al., 2011)
Sema3F-unknown receptor
Sema7a-unknown receptor
? ? ?
EphrinB2-EphB4 VEGFR2/3 endocytosis
(Sawamiphak et al., 2010b;
Wang et al., 2010b)
? ?
Slit2-Robo4 ? Arf6/Rac (Jones et al., 2009) ?
NogoA-S1PR2? RhoA? (Wa¨lchli et al., 2013) ?
NogoB-NgBR ? Akt (Zhao et al., 2010)
Sonic hedgehog-Ptch/Smo VEGF-A isoforms[ (Pola et al., 2001)
CNS-Specific Regulators of Angiogenesis
Wnt7a/b-(Fzd6) ? ? ?
Norrin-Fzd4 ? ? VEGF-A, VEGFR1, VEGFR2, Nrp1,
Nrp2[ (Wang et al., 2012)
Unknown ligand-GPR124 ? ? VEGF-A[ (Cullen et al., 2011)
Unknown ligand-DR6/TROY ? JNK (Tam et al., 2012) ?
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Reviewthe intersegmental boundaries but form ectopic branches along
the trunk (Torres-Va´zquez et al., 2004). This mispatterning was
described for ISVs, but it is unknown whether CNS vessel
patterning is also affected (Torres-Va´zquez et al., 2004).
Addition of Semaphorin-3A to Plexin-D1-expressing HUVECs
leads to collapse of actin stress fibers and migration inhibition
in vitro suggesting a direct guidance mechanism via effects on
the actin cytoskeleton (Torres-Va´zquez et al., 2004). However,
a recent study proposed an alternative mechanism, namely
interaction of Semaphorin-3A1/A2-Plexin-D1 with the VEGF
signaling pathway (Zygmunt et al., 2011) (Figure 4B; Table 2).
Plexin-D1 was shown to be necessary in endothelial cells for
the regulation of soluble Flt1 (sFlt1) expression, a splice variant
of VEGFR1 acting as a decoy receptor (blocking VEGFRand stalk cells but are—for simplicity—only displayed on one endothelial cell type
regulate multiple aspects of angiogenesis: vessel guidance (either as attractive or
cell selection. CNS-specific cues for angiogenesis additionally regulate blood-br
(B) Molecules of the neurovascular link (either CNS-specific or general/non-CNS
at multiple levels to affect different angiogenic functions: (1) to affect tip cell guida
D1, Semaphorin-3E-Plexin-D1 (RhoJ), or EphrinB2-EphB4, (2) to determine the
b-catenin, (3) to regulate sprouting angiogenesis via interactions with the VEGF
modulate VEGF receptor endocytosis, e.g., EphrinB2-EphB4, and (5) to modu
However, some evidence also suggests that not all molecular players converge t
specific cue GPR124 as well as Nogo-A seem to regulate angiogenesis without
amples of molecules that regulate vascular morphogenesis independently of the V
cell; UL, unknown ligand; UR, unknown receptor.signaling) (Figure 4B). Accordingly, the loss of sFlt1 in Plexin-
D1 mutants leads to an increased number of endothelial tip cells
and subsequent hyperbranching (Zygmunt et al., 2011).
Although Semaphorins-3A1/3A2 and Plexin-D1 seem to be ex-
pressed in the CNS (Torres-Va´zquez et al., 2004; Zygmunt
et al., 2011), no functional data with regard to its effects on brain
angiogenesis is available in zebrafish.
During embryonic mouse development, Semaphorin-3A is
expressed at E10 in vascular endothelial cells in the spinal
cord and in the dorsal aorta (Serini et al., 2003). Interestingly,
at E12.5, endothelial cells of perineural blood vessels that sprout
into the brain parenchyma express Semaphorin-3A, indicating
its expression on active, sprouting endothelium (Serini et al.,
2003). Thus, endothelial Semaphorin-3A expression does not. The different (CNS-specific or generally/globally acting) ligand-receptor pairs
repulsive cues), endothelial proliferation and tube formation as well as tip/stalk
ain barrier-formation and differentiation. See also Tables S1–S4.
specific) interact with the canonical angiogenic VEGF-A/C-VEGFR2/3 pathway
nce via cytoskeleton regulation, e.g., Netrin-1-Unc5b, Semaphorin-3A-Plexin-
tip-to-stalk cell ratio via Dll4/Notch, e.g., Semaphorin-3E-Plexin-D1 or Wnt/
-pathway, e.g., Nogo-B-NgBR (Akt), DR6/TROY (JNK), or Unc5b (Src), (4) to
late vascular permeability and tube formation, e.g., Slit2-Robo4 (Arf6, Rac).
oward the VEGF-VEGFR-Dll4-Jagged-Notch pathway. For example, the CNS-
massive effects on VEGF-A-VEGFR2-Dll4-Jagged-Notch signaling. Other ex-
EGF pathway are FGF and BMP. See also Tables S1–S4. TC, tip cell; SC, stalk
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Table 3. Developmental Brain/SC versus Retina versus Non-CNS Angiogenesis
Developmental Brain and Spinal Cord Angiogenesis Developmental Retinal Angiogenesis
Embryonic Angiogenesis
Developmental process Ligand-receptor pair Developmental process Ligand-receptor pair
E8.5: PNVP formation
(vasculogenesis)
VEGF-A-VEGFR2 The neuronal retina remains avascular
during embryonic stages
E9.5: INVP formation
(sprouting from PNVP into
CNS parenchyma):
VEGF-A-VEGFR2
Wnt7a/7b-unknown receptor
Unknown ligand-GPR124
E9.5–P25: INVP formation
(angiogenic sprouting and
migration toward the SVZ)
VEGF-A-VEGFR2
Unknown ligand-Neuropilin
Semaphorin-3E-Plexin D1
Ephrin B2-Eph B4
Slit 2-Robo 4
Postnatal Angiogenesis
E9.5–P25: INVP formation
(sprouting angiogenesis and
remodeling?)
VEGF-A-VEGFR2
Nogo-A-(S1PR2?)
Thyroid hormone-unknown
receptor?
P0–P7: formation of superficial
retinal vascular plexus (sprouting
angiogenesis [radial, 2D])
VEGF-A/B/C-VEGFR1/2/3
Netrin-1-Unc5b
Semaphorin-3E-Plexin D1
Ephrin B2-Eph B4
Slit 2-Robo 4
Nogo-A-(S1PR2?)
P7–P14: formation of deeper retinal vascular
plexi (sprouting angiogenesis into deeper
plexi [vertical, 3D] and sprouting angiogenesis
within deeper plexi [radial, 2D])
Wnt-VEGFR1
Norrin-Frizzled4
Nogo-A-(S1PR2?)
Ligand-Receptor Pairs with Global Functions in Angiogenesis and Vascular Patterning
Ligand-receptor pair Retinal angiogenesis Brain/s.c. angiogenesis Non-CNS angiogenesis
VEGFA/B/C-VEGFR1/2/3 Yes (Gerhardt et al., 2003;
Stone et al., 1995)
Yes (Carmeliet et al., 1996; Ferrara
et al., 1996)
Yes (Carmeliet et al., 1996;
Ferrara et al., 1996)
Netrin-1-Unc5b Yes (Lu et al., 2004) Yes (Lu et al., 2004) Yes (Lu et al., 2004; Park
et al., 2004)
Netrin-4-Unc5b Yes (Lejmi et al., 2008),
pathological angiogenesis only
? Yes (Wilson et al., 2006)
Semaphorin-3A-Plexin-D1 ? ? Yes (Serini et al., 2003;
Torres-Va´zquez et al., 2004)
Semaphorin-3E-Plexin-D1 Yes (Kim et al., 2011) ? Yes (Gu et al., 2005)
Semaphorin-3F-unknown receptor
Semaphorin-7A-unknown receptor
? ? ?
EphrinB2-EphB4 Yes (Sawamiphak et al., 2010b;
Wang et al., 2010b)
Yes (Sawamiphak et al., 2010b) Yes (Sawamiphak et al.,
2010b; Wang et al., 2010b)
Slit2-Robo4 Yes (Jones et al., 2008; Wang
et al., 2003)
? Yes (Bedell et al., 2005)
NogoA-S1PR2? Yes (Wa¨lchli et al., 2013) Yes (Wa¨lchli et al., 2013) ?
NogoB-NgBR ? ? Yes (Miao et al., 2006; Zhao
et al., 2010)
Sonic hedgehog-Ptch/Smo ? ? Yes (Nagase et al., 2008;
Pola et al., 2001)
CNS-Specific Regulators of Angiogenesis
Ligand-receptor pair Retinal angiogenesis Brain/s.c. angiogenesis Non-CNS angiogenesis
Wnt7a/b-(Fzd6) ? Yes (Daneman et al., 2009; Stenman
et al., 2008)
No (Daneman et al., 2009;
Stenman et al., 2008)
Norrin-Fzd4 Yes (Xu et al., 2004), regulation
of BBB integrity in the brain
Yes (Wang et al., 2012) Yes (Luhmann et al., 2005;
Rehm et al., 2002)
Unknown ligand-GPR124 ?(Kuhnert et al., 2010)
- GPR124 is also expressed in
retinal ECs
Yes (Anderson et al., 2011; Cullen
et al., 2011; Kuhnert et al., 2010)
No (Anderson et al., 2011;
Cullen et al., 2011; Kuhnert
et al., 2010)
Unknown ligand-DR6/TROY ? Yes (Tam et al., 2012) No (Tam et al., 2012)
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seems to be selectively expressed on angiogenic but not on
quiescent endothelial cells.
Functionally, endothelial Semaphorin-3A is a regulator of
vascular branching in mouse and chick CNS and non-CNS
organs (Acevedo et al., 2008; Serini et al., 2003). Semaphorin-
3A/ mice showed decreased vascular branching in cranial
blood vessels (CNS) and in trunk ISVs (non-CNS) at E9.5 (Serini
et al., 2003). Remodeling of the developing chick PNVP into
small capillaries and large-caliber vessels is severely affected
by overexpression of Semaphorin-3A/F, of Nrp-1, or of Plexin-
A1. This PNVP-remodeling is integrin dependent (Serini et al.,
2003). Accordingly, in vitro, Semaphorin-3A inhibited integrin-
mediated adhesion of endothelial cells on the ECM-ligands vitro-
nectin and fibronectin and also inhibited directed migration of
HUVECs toward fibronectin and vitronectin gradients in a
Plexin-A1- and Nrp-1-dependent manner (Serini et al., 2003).
According to Serini et al., Semaphorin-3A negatively regulates
integrin activity to modulate endothelial cell adhesion andmigra-
tion therefore allowing proper vascular branching and remodel-
ing during sprouting angiogenesis in vivo (Serini et al., 2003).
Semaphorin-3A also inhibits developmental angiogenesis in
the chick CAM (Acevedo et al., 2008) and the quail limb buds
(Bates et al., 2003). However, despite the above-mentioned
evidence, the role of Semaphorin-3A on developmental angio-
genesis has been questioned as other studies showed that
Semaphorin-3A/ mice do not display any vascular phenotype
in vivo (Vieira et al., 2007) and no effects on endothelial cell
migration and adhesion in vitro (Pan et al., 2007).
In the postnatal mouse retina (P5 to P8), Semaphorin-3A-
Nrp-1 signaling regulates sprouting angiogenesis and vessel re-
modeling (Pan et al., 2007). Intraocular injection of anti-Nrp-1
antibody blocking Semaphorin-3A-Nrp-1 binding shows that
Semaphorin-3A-Nrp-1 signaling induces vascular remodeling
in the mature parts of the superficial retinal plexus (Pan et al.,
2007). In contrast, the anti-Nrp-1 antibody as well as an anti-
VEGF antibody inhibited sprouting angiogenesis into the deeper
layers of the retina, suggesting pro-angiogenic roles for Sema-
phorin-3A. Surprisingly, in vitro, addition of anti-Nrp-1 antibody
had only minor effect on VEGF-VEGFR2 signaling (Figure 4B).
Taken together, although these data suggest that Sema-
phorin-3A regulates angiogenesis in the CNS and the periphery,
the molecular mechanisms including the interactions with the
VEGF-VEGFR pathway remain elusive (Figures 4A and 4B;
Tables 2 and 3; Table S2).
Semaphorin-3E. Semaphorin-3E is a special case among the
Class 3 Semaphorins because it is the only family member that
does not bind to Nrp-1 but directly to the signal-transducing
unit Plexin-D1 to initiate downstream signaling (Gu et al., 2005)
(Figure 4A). Semaphorin-3E-Plexin-D1 signaling negatively regu-
lates angiogenesis in- and outside the CNS via interaction with
the VEGF-VEGFR-DLL4-Jagged-Notch pathway (Figures 4A
and 4B; Tables 2 and 3; Table S2).
In zebrafish, Semaphorin-3E and Semaphorin receptors
Plexin-D1 and -B2 are expressed in endothelial cells of the dorsal
aorta (DA), from which ISVs form (Lamont et al., 2009). Sema-
phorin-3E and Plexin-B2 morphants show a delayed outgrowth
of ISVs but no apparent guidance defects, which is distinctfrom the Plexin-D1 mutant obd and Plexin-D1 morphants
described above (Torres-Va´zquez et al., 2004). Transplantation
experiments in zebrafsh indicate that endothelial Semaphorin-
3E signals to endothelial Plexin-B2 in paracrine and autocrine
manners to regulate the precise timing of ISV formation, by a
yet unknown molecular mechanism (Lamont et al., 2009). These
data suggest that different Semaphorin-Plexin ligand-receptor
pairs display different functions in zebrafish ISV angiogenesis,
i.e., Semaphorin-3A-Plexin-D1 acting on vascular guidance/
patterning (Torres-Va´zquez et al., 2004; Zygmunt et al., 2011),
whereas Semaphorin-3E-Plexin-B2 controls the initiation and
timing of ISV sprouting. The expression of Semaphorin-3E and
Plexin-B2 onCNS vessels and possible functions on brain angio-
genesis in these mutants were not investigated.
In the mouse, Semaphorin-3E is a negative regulator of ISV
angiogenesis (Gu et al., 2005). In contrast to the situation in
zebrafish (Lamont et al., 2009), Semaphorin-3E is expressed
on somites, whereas similar to zebrafish, mouse Plexin-D1 is ex-
pressed on ISV endothelial cells (Gu et al., 2005), suggesting
different cellular mechanism between these species.
Binding studies showed that Semaphorin-3E specifically binds
Plexin-D1 but not Nrp-1 in vivo and in vitro (Gu et al., 2005).
Accordingly, Plexin-D1/ mice display excessive branching of
ISVs into Semaphorin-3E expressing somites, while in vivo
overexpression of Semaphorin-3E in chicken somites creates re-
gions devoid of blood vessels, indicating that Semaphorin-3E-
Plexin-D1 negatively regulates angiogenesis and functions as
repulsive cue in vascular guidance (Gu et al., 2005). Interestingly,
Semaphorin-3E-Plexin-D1 function is not restricted to non-CNS
vessels: in the mouse retina at P2–P6, endothelial Plexin-D1
expression is highly enriched at the sprouting front including
endothelial tip and stalk cells as well as veins but is absent
from mature vessels and arteries, indicating its role in active
sprouting angiogenesis (Fukushima et al., 2011; Kim et al.,
2011). At the same developmental time points, Semaphorin-3E
is expressed in retinal ganglion cells over the entire retina and
therefore not restricted to sites of active angiogenesis (Fukush-
ima et al., 2011; Kim et al., 2011), indicating that the receptor
rather than the ligand expression spatially specifies angiogenic
sites.
Functionally, Semaphorin-3E/ and Plexin-D1/ mice dis-
play vascular patterning defects characterized by an unevenly
growing retinal vascular front (Kim et al., 2011), whereas injection
of function-blocking Plexin-D1-Fc increased vascular branching
and neuronal Semaphorin-3E restricts endothelial migration into
the deeper retinal plexus (Fukushima et al., 2011), thereby sug-
gesting negative regulatory effects of Semaphorin-3E-Plexin-
D1 on postnatal angiogenesis via neuro-vascular interactions
in the CNS. Whether Semaphorin-3E-Plexin-D1 signaling inter-
acts with VEGF-A-VEGFR2 signaling to regulate PNVP and
INVP formation in the developing neural tube and brain remains
to be explored.
Mechanistically, Semaphorin-3E-Plexin-D1 signaling leads to
downstream activation of the small GTPase RhoJ expressed in
endothelial cells and subsequent retraction of retinal endothelial
filopodia (Fukushima et al., 2011) (Figure 4B). In line with this
idea, intraocular injection of Plexin-D1-Fc induced the formation
of more filopodia in tip cells and increased vascular density in theNeuron 87, July 15, 2015 ª2015 Elsevier Inc. 283
Neuron
Reviewplexus, likely via RhoJ (Fukushima et al., 2011). This molecular
interaction is effective during retinal development, in cultured
non-CNS endothelial cells (HUVEC) in vitro as well as in ischemic
retinopathy in vivo, where Plexin-D1-RhoJ selectively inhibits
pathological extraretinal neovessel ingrowth without affecting
normal (non-pathological) retinal vessels (Fukushima et al.,
2011).
Furthermore, Semaphorin-3E-Plexin-D1 activation inhibits
VEGF-induced Dll4 expression in retinal endothelial cells in vivo
and in HUVECs in vitro, thereby regulating the tip/stalk cell selec-
tion in CNS and non-CNS endothelial cells (Fukushima et al.,
2011) (Figure 4B; Table 2). Semaphorin-3E/ mice display
increased Dll4 levels in retinal endothelial cells leading to
increased Notch signaling and a subsequent decreased number
of endothelial tip cells and this phenotype could be rescued by
the Dll4/Notch signaling inhibitor DAPT (Kim et al., 2011).
Accordingly, intraocular injection of Semaphorin-3E caused a
downregulation of endothelial Dll4, whereas injection of function
blocking Plexin-D1-Fc upregulated endothelial Dll4 expression
(Kim et al., 2011).
Interestingly, VEGF-A-VEGFR2 and Semaphorin-3E-Plexin-
D1 are involved in a negative feedback mechanism involving
Dll4 (Figure 4B): VEGF-A-VEGFR2 signaling leads to upregula-
tion of endothelial Dll4 and Plexin-D1 in tip cells, while
Semaphorin-3E-Plexin-D1 signaling downregulates endothelial
Dll4 expression in tip cells (Kim et al., 2011). Therefore, VEGF-A
directly activates Dll4-Notch signaling and indirectly inhibits
Dll4-Notch signaling via Plexin-D1 upregulation (Kim et al.,
2011). Accordingly, intraocular injection of VEGF-A leads to an
expanded Plexin-D1 expression toward the more mature
vascular plexus to inhibit active sprouting.
The observed phenotypes suggest two distinct underlying
molecular mechanisms at work in the developing retina: repul-
sive effects on migration to regulate sprouting into the deeper
retina and modulation of tip/stalk cell selection to ensure normal
sprouting at the retinal vascular front, presumably via the modu-
lation of the VEGF-VEGFR pathway (Figure 4B; Table 2).Whether
these mechanisms hold true in tissues outside the CNS remains
to be determined. Although Nrp-1 is a receptor for Semaphorin
ligands in neural development, the precise role for the ligand re-
ceptor pair Semaphorin-3 s-Nrps on angiogenesis is debated:
whereas Semaphorin-3E interacts with Plexin-D1 independently
of Nrp-1 to inhibit angiogenesis (Gu et al., 2005), the precise role
for the ligand receptor pair Semaphorin-3A-Nrps on develop-
mental angiogenesis in vivo is less clear. As Nrp-1 binds Sema-
phorin-3 s but also VEGF-A (Soker et al., 1998), it is difficult to
precisely distinguish between effects of Semaphorin-3A-Nrp-1
versus VEGF-A-Nrp-1 signaling (Gu et al., 2005; Serini et al.,
2003).
While the in vivo function of Semaphorin-3A in mouse is
controversial (see above), Nrp-1 has a well-described function
in tip cells during angiogenic sprouting in the CNS (Fantin
et al., 2013a; Gerhardt et al., 2004). In the embryonic mouse,
Nrp-1 is expressed in endothelial tip and stalk cells of vascular
sprouts invading the brain parenchyma at E10.5–E11.5 as well
as on neural progenitors and on macrophages (Fantin et al.,
2013a; Gerhardt et al., 2004). In Nrp-1/ mice, endothelial tip
cell filopodia fail to reorient from their initial direction along radial284 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.glia processes to a perpendicular direction along the ventricles,
suggesting a guidance function for Nrp-1 (Gerhardt et al., 2004).
Interestingly, endothelial cells with higher Nrp-1 levels have a
higher chance to become a tip cell rather than a stalk cell during
CNS sprouting angiogenesis in vivo, suggesting an important
role for Nrp-1 in tip cell selection and function (Fantin et al.,
2013a).
In summary, Semaphorin-3A and Semaphorin-3E regulate
angiogenesis in CNS and non-CNS tissues acting predominantly
as negative angiogenic cues (Table 3; Table S2).
Other Semaphorins. Notably, some pro-angiogenic roles of
Semaphorins apart for Semaphorin-3A (see above) have been
described for Semaphorin-6D and Plexin-A1 (Toyofuku et al.,
2004), Semaphorin-4A and Plexin-D1 (Toyofuku et al., 2007),
and for Semaphorin-5A (Fiore et al., 2005), whereas all these
ligand-receptor pairs do not show any specificity for CNS angio-
genesis.
Nogo Proteins and Their Receptors in Angiogenesis
Nogo-B. Nogo-B and its specific receptor NgBR, which was
initially characterized in the vasculature, play a crucial role as
pro-angiogenic cues during developmental non-CNS angiogen-
esis in the embryonic zebrafish via interaction with the VEGF
signaling pathway (Figures 4A and 4B; Tables 2 and 3; Table
S3) (Miao et al., 2006; Zhao et al., 2010).
At 24 hpf, Nogo-B expression was found on somites and in the
brain, while NgBR was expressed on endothelial cells of ISVs
and of the DA, as well as in neural tissue of the brain (Zhao
et al., 2010). Morpholino-mediated knockdown of Nogo-B or
NgBR lead to absent or misoriented ISVs at 24 hpf. However,
vasculogenesis (angioblast proliferation and migration) were
not disturbed upon NgBR knockdown, suggesting that the
Nogo-B-NgBR ligand receptor pair acts primarily to regulate
sprouting angiogenesis in vivo (Zhao et al., 2010). Nogo-B and
NgBR expression patterns on CNS endothelial cells as well as
effects of Nogo-B or NgBR knockdown on CNS angiogenesis
were not investigated but would be interesting to address in light
of the expression of these proteins in the brain (see above).
In the adult mouse, Nogo-B is expressed in endothelial cells
and vascular smooth muscle cells of different (non-CNS) blood
vessels including the femoral and carotid arteries and the coro-
nary vessels as well as on HUVECs (Acevedo et al., 2004).
With regard to the CNS, Nogo-B is detectable in adult mouse
brain extracts as well as in adult and postnatal mouse cortical
endothelial cells (Acevedo et al., 2004; Wa¨lchli et al., 2013), sug-
gesting a Nogo-B expressed in endothelial and other cell types
in- and outside the CNS. NgBR, the receptor of Nogo-B, is
also expressed in the adult mouse, in a variety of non-CNS
organs such as the heart, liver, kidney, and pancreas but was
not detectable in brain extracts (Miao et al., 2006) suggesting a
possible role of NgBR on angiogenesis in vascular patterning
only outside the CNS. NgBR is expressed in HUVECs (Acevedo
et al., 2004;Miao et al., 2006; Zhao et al., 2010) but its expression
on CNS endothelial cells as well as the role of Nogo-B-NgBR in
CNS angiogenesis is not known.
Current literature suggests that Nogo-B is a positive and
Nogo-A a negative regulator of angiogenesis (Wa¨lchli et al.,
2013; Zhao et al., 2010). Interestingly, Nogo-A/B/ mice are
viable and fertile (Schwab, 2010) and show no obvious defects
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patterning (Yu et al., 2009). Given the opposing roles of the
two Nogo-isoforms (Acevedo et al., 2004; Wa¨lchli et al., 2013),
it is therefore possible that the lack of vascular phenotype in
the double knockout mice is due to a compensation mecha-
nisms between the two Nogo isoforms or due to a compensation
by other molecules as shown for the Nogo-A KO mouse where
several Semaphorins and Ephrins are upregulated (Kempf
et al., 2013). Taken together, Nogo-B’s in vivo expression and
function in developmental angiogenesis in- and outside the
CNS awaits further investigation.
Mechanistically, Nogo-B-NgBR signaling and VEGF-VEGFR2
signaling crosstalk at the level of Akt (Figure 4B; Table 2; Table
S3), which is a common downstream target (Miao et al., 2008;
Zhao et al., 2010). Small interfering RNA-mediated knockdown
of NgBR inHUVECs reduces VEGF-stimulated HUVECmigration
and tube formation via reduced Akt phosphorylation (Zhao et al.,
2010). Thus, VEGF-A and Nogo-B induce Akt phosphorylation in
aNgBR-sensitive way. Accordingly, constitutively active Akt was
able to partially rescue these inhibitory effects of NgBR knock-
down on VEGF-induced HUVEC migration in vitro as well as
the ISV sprouting defects in Nogo-B- and NgBR zebrafish mor-
phants in vivo (Zhao et al., 2010).
Taken together, Nogo-B promotes developmental angiogen-
esis of ISVs via endothelial NgBR and interacts with VEGF-
related pathways at the level of Akt (Acevedo et al., 2004; Miao
et al., 2006; Zhao et al., 2010). The precise expression pattern
of Nogo-B/NgBR on endothelial cells (i.e., tip versus stalk cell
expression), a possible functional relevance of Nogo-B-NgBR
during developmental CNS angiogenesis as well as further
investigation of the above-described interactions between
Nogo-B/NgBR and VEGF-VEGFR2-Akt are interesting questions
for future investigations.
In several models of pathological neo-angiogenesis outside
the CNS, for instance, VEGF-induced ear angiogenesis and
wound-healing angiogenesis, Nogo-B and NgBR are expressed
on smooth muscle cells and endothelial cells of angiogenic and
mature blood vessels, consistent with their role as pro-angio-
genic cues (Acevedo et al., 2004; Kritz et al., 2008; Miao et al.,
2006). However, Nogo-B also exerts repulsive effects on
vascular cells, as it inhibits vascular smooth muscle cell
(VSMC) migration in vitro (Acevedo et al., 2004; Kritz et al.,
2008). In adult mice, loss of endothelial and VSMC Nogo-B
from the femoral artery vessel wall after injury leads to increased
neointima formation caused by VSMC proliferation and migra-
tion and subsequent vessel stenosis (Acevedo et al., 2004; Kritz
et al., 2008), thereby further supporting an inhibitory effect of
Nogo-B on blood vessels.
Nogo-A. Nogo-A’s important function for growing neurons
during development and after CNS injuries is supported by a
large body of data (Schwab, 2010), yet very little is known about
Nogo-A’s function in angiogenesis in- and outside the CNS
(Table 3; Table S3). We have recently identified Nogo-A as a
negative regulator of developmental CNS angiogenesis (Wa¨lchli
et al., 2013) and showed that Nogo-A is expressed throughout
the postnatal mouse brain as well as in the retina at postnatal
stages P4 and P8 (Wa¨lchli et al., 2013). At the cellular level,
Nogo-A is found in postnatal cortical neurons and retinal gan-glion cells, in immediate vicinity of CNS blood vessels and endo-
thelial tip cells and their filopodia, but not on endothelial cells.
Nogo-A protein was not expressed in postnatal cortical endo-
thelial tip cells in vivo, as well as in postnatal and adult brain
MVECs (Wa¨lchli et al., 2013). Nogo-A gene deletion (Nogo-
A/) or treatment with anti-Nogo-A antibody (Oertle et al.,
2003) leads to a significantly increased blood vessel density in
the aforementioned brain regions at P8 (Wa¨lchli et al., 2013).
Moreover, in the retina, Nogo-A/ mice revealed an increased
radial migration of the forming vessel plexus at P4, and an
increased vessel density in the deeper retinal layers in
Nogo-A/ and Nogo-A Ab-treated animals (Wa¨lchli et al.,
2013). These results suggest a cellular mechanism where
Nogo-A expressed by CNS neurons interacts with vascular
endothelial cells, thereby negatively regulating sprouting angio-
genesis in the postnatal CNS in vivo. Accordingly, the Nogo-A-
specific domain Nogo-A Delta 20 inhibited the spreading,
migration and sprout formation of brain MVECs (Wa¨lchli et al.,
2013). Addition of soluble Nogo-A Delta 20 to mouse brain
MVEC cultures led to quick retraction of MVEC lamellipodia
and filopodia (Wa¨lchli et al., 2013). The repulsive effects of
Nogo-A Delta 20 on CNS endothelial cells and its filopodial
and lamellipodial protrusions were mediated via the Rho-A
ROCK-Myosin II pathway, which has described roles in lamelli-
podial and filopodial motility in non-CNS endothelial cells (De
Smet et al., 2009; Fischer et al., 2009). Notably, the second inhib-
itory domain of Nogo-A, Nogo-66, did not show any inhibitory
effects on brain-derived MVEC cell spreading, migration, and
lamellipodia and filopodia motility in vitro (Wa¨lchli et al., 2013).
This is in contrast to Nogo-A’s described role on neurons, where
Nogo-66 and Nogo-A Delta 20 both exert inhibition of neurite
outgrowth and lead to growth cone collapse (Oertle et al., 2003).
Non-CNS angiogenesis was not tested so far but since
Nogo-A expression has been described at developmental
stages in different peripheral tissues such as heart and skin
(Schwab, 2010), it is tempting to speculate that angiogenesis
and vascular patterning in vascular beds outside the CNS could
also be affected by Nogo-A. Whether Nogo-A signaling interacts
with VEGF-A-VEGFR2 signaling to regulate CNS angiogenesis in
the developing neural tube and brain is currently unclear.
The number of brain cortical endothelial tip cells was
increased in conditions lacking functional Nogo-A (Wa¨lchli
et al., 2013). Whether this regulation of the tip cell number in-
volves an interaction with the VEGF-VEGFR2-Dll4-Jagged-
Notch signaling axis is not understood (Figure 4B; Table 2; Table
S3). Although earlier studies have reported an upregulation of
VEGF-A mRNA in spinal cords treated with anti-Nogo-A Ab
(Bareyre et al., 2002), protein levels of phosphorylated (activated)
and total VEGFR2 protein as well as mRNA levels of VEGFA,
VEGFR2, Dll4, and Notch4 were unchanged in P8 Nogo-A/
whole brain lysates (Wa¨lchli et al., 2013). Moreover, MVECs
treated with Nogo-A Delta 20 showed no effect on p-VEGFR2
and total VEGFR2 levels (Wa¨lchli et al., 2013). Given the predom-
inant role of VEGF-VEGFR-Dll4-Jagged-Notch pathway (Blanco
andGerhardt, 2013) in the regulation of the number of endothelial
tip cells and in light of the observations described above,
possible interactions of the Nogo-A- and the VEGF-pathways
deserve further investigation.Neuron 87, July 15, 2015 ª2015 Elsevier Inc. 285
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ditions is almost completely unknown. Only one recent article
described an increased vascularization of hydrogels implanted
into the lesioned spinal cord of rats supplemented with anti-
NgR1 antibodies (Wei et al., 2010), thereby suggesting a repul-
sive function for the Nogo-66 receptor NgR1 in pathological
angiogenesis. However, as we and others found neither NgR1
expression in CNS endothelial cells during development and in
the adult (Acevedo et al., 2004; Wa¨lchli et al., 2013) nor effects
of Nogo-66 on in vitro CNS endothelial cell motility (Wa¨lchli
et al., 2013), these seemingly contradictory observations point
toward differences between physiological and pathological
angiogenesis, which need to be further examined.
Taken together, neuronal Nogo-A negatively regulates devel-
opmental mouse CNS angiogenesis. It is tempting to speculate
that the recently identified Nogo-A Delta 20-specific receptor
S1PR2 (Kempf et al., 2014) (Figures 1B, 4A, and 4B) mediates
these repulsive effects on the vasculature.
In summary, current data suggest a model in which the Nogo
family of proteins provides angiogenic cues with Nogo-A being a
negative regulator of CNS angiogenesis and Nogo-B a positive
regulator of non-CNS angiogenesis (Table 3; Table S3).
Cns-Specific Mechanisms of Angiogenesis
Wnts and Their Receptors in Angiogenesis
To date, only few molecules have been involved in CNS-specific
angiogenesis (Table S4). One recent example is Wnt7a/b-b-cat-
enin signaling that was shown to regulate CNS angiogenesis and
barriergenesis (Daneman et al., 2009; Liebner et al., 2008; Sten-
man et al., 2008).
During mouse embryogenesis, Wnt ligands are expressed by
the neuroepithelium and interact with Frizzled (Fzd) receptors ex-
pressed on CNS endothelial cells (Daneman et al., 2009; Liebner
et al., 2008; Stenman et al., 2008). In the developing CNS at
E10.5/E11.5,Wnt7a andWnt7b are expressed by neural progen-
itors in ventral (but not dorsal) regions of the forebrain and the
spinal cord (Daneman et al., 2009) and are also expressed in
embryonic non-CNS tissues such as the ectoderm and the
dermatome (Niswander, 2003). Interestingly, at E12.5 down-
stream targets of Wnt signaling such as Lef1 and Axin2
are more abundantly expressed in brain endothelial cells as
compared to peripheral endothelial cells of liver and lung,
thereby revealing CNS-specific expression and activity patterns.
Moreover, Wnt signaling reporter mice (TOP-gal) displayed
CNS-specific Wnt activation in endothelial cells (Daneman
et al., 2009). Whereas Frizzled 4, Frizzled 6, and Frizzled 8 are ex-
pressed on CNS and non-CNS endothelial cells (of the lung and
of the liver), Frizzled 6 expression is significantly higher in CNS
endothelial cells and expressed at E11.5 mouse forebrain and
spinal (Daneman et al., 2009), thereby revealing a CNS-specific
expression pattern.
Genetic deletion of the Wnt ligands Wnt7a and Wnt7b (single
and double mutants), delivery of a Wnt inhibitor (soluble
Frizzled8-Fc) or endothelial-specific deletion of b-catenin, a
Wnt effector protein involved in canonical Wnt signaling, all
lead to severe disturbances of the CNS vasculature (Daneman
et al., 2009; Stenman et al., 2008). Sprouting into the forebrain
was almost completely abolished, resulting in a thickened286 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.PNVP. Endothelial cells stuck in the PNVP consequently formed
large, malformed vessels with multiple layers of endothelial cells
with a lumen only in some cases (Daneman et al., 2009; Stenman
et al., 2008) and these vascular malformations showed an
increased risk of hemorrhage into the nervous tissue (Daneman
et al., 2009; Stenman et al., 2008). Interestingly, these effects
of Wnt/b-catenin showed region specificity, as the capillary
beds in the posterior regions of the cortex as well as in the hind-
brain of these b-catenin mutant mice were not affected. Most
importantly, angiogenesis outside the CNS, namely in the liver,
in the lung, and in the heart, was not affected in all conditions
lacking functional Wnt/b-catenin signaling, demonstrating a
CNS-specific role for Wnt/b-catenin in angiogenesis (Daneman
et al., 2009; Stenman et al., 2008).
The important pro-angiogenic role forWnt7a onCNS endothe-
lium was further supported by the finding that Wnt7a—but not
VEGF-A—enhanced the in vitro migration of a mouse brain
endothelial cell line (bEND3.0 cells) (Daneman et al., 2009).
Non-CNS endothelial cells were not tested here. The finding
that VEGF-A expression was not changed upon Wnt7 deletion
(Daneman et al., 2009; Stenman et al., 2008) in CNS tissue sug-
gested independence of theWnt7- and VEGF-A pathways. How-
ever, as Wnt- and VEGF-A signaling have both been implicated
in sprouting angiogenesis into the developing CNS tissue
(INVP) (Bautch, 2012; Hogan et al., 2004; James et al., 2009;
Mancuso et al., 2008) in vivo, a crosstalk between these path-
ways remains possible.
In addition to its role on CNS angiogenesis, Wnt signaling is
also involved in the formation and differentiation of the BBB
(Table 4): Wnt7a increases endothelial expression of the BBB-
specific influx transporters such as Glut-1, Cat1, and Ta1
in vitro and controls endothelial Glut-1 expression in vivo (Dane-
man et al., 2009) (see also Table 1). Strikingly, Wnt/b-catenin
signaling can also induce BBB properties in non-brain derived-
endothelial cells (Liebner et al., 2008), suggesting that Wnts
are important cues in the CNS microenvironment, capable of
inducing CNS-specific properties in endothelial cells. In sum-
mary, whereas Wnt7a gain of function induces a profound effect
on the expression of the CNS vessel-specific transporter Glut1 in
non-CNS vasculature but does not display ectopic or enhanced
vessel ingression, the loss of Wnt7a/Wnt7b function exhibits se-
vere vessel ingression defects (Stenman et al., 2008). Therefore,
one intriguing possibility may be that Wnt7s can be permissive
signals that are required for VEGF-A-mediated vessel ingression
to proceed normally, whereas Wnt signaling is instructive for the
acquisition of BBB characteristics. How and if the canonical Wnt
signaling pathway interacts with VEGF signaling to control INVP
formation in the brain and neural tube remains obscure.
A different, however non-CNS-specific, function for Wnt
signaling is mediated by another Frizzled ligand called Norrin
(Xu et al., 2004). Norrin is a small protein with the ability to acti-
vate the Wnt pathway via its interaction with Frizzled4-LRP5 re-
ceptors. Defects in these genes cause defects in the retinal
vasculature in which especially sprouting into the deeper retinal
layers is impaired (Wang et al., 2012; Xu et al., 2004; Ye et al.,
2009). However, Norrin-Frizzled4 is also involved in inner ear
angiogenesis (Xu et al., 2004) and Norrin, Wnt2, and Frizzled5
regulate placental angiogenesis (Ye et al., 2010). Norrin-Frizzled
Table 4. General- and CNS-Specific Regulators of Angiogenesis
Ligand-Receptor Pairs Barriergenesis (BBB) References
Global Functions in Angiogenesis and Vascular Patterning
VEGFA/B/C-VEGFR1/2/3 ? (vascular permeability) Carmeliet et al. (1996); Ferrara et al. (1996)
Netrin-1-Unc5b No (modulation of vascular
permeability)
Bouvre´e et al. (2008); Koch et al. (2011); Larrive´e et al. (2007); Liu et al.
(2004); Lu et al. (2004); Navankasattusas et al. (2008); Park et al. (2004)
Netrin-4-Unc5b No (modulation of vascular
permeability)
Hoang et al. (2009); Lambert et al. (2012); Larrieu-Lahargue et al. (2010,
2011); Lejmi et al. (2008); Nacht et al. (2009)
Semaphorin-3A-Plexin-D1 No (modulation of vascular
permeability)
Acevedo et al. (2008); Cerani et al. (2013); Pan et al. (2007); Serini et al.
(2003); Torres-Va´zquez et al. (2004); Zygmunt et al. (2011)
Semaphorin-3E-Plexin-D1 No Fukushima et al. (2011); Gu et al. (2005); Kim et al. (2011); Lamont et al.
(2009)
Semaphorin-3F-unknown receptor
Semaphorin-7A-unknown receptor
No (modulation of vascular
permeability)
Coma et al. (2011); Morote-Garcia et al. (2012); Sultana et al. (2012);
Wong et al. (2012)
EphrinB2-EphB4 No Adams et al. (1999); Sawamiphak et al. (2010b); Wang et al. (1998, 2010b)
Slit2-Robo4 No (modulation of vascular
permeability)
Jones et al. (2008, 2009)
NogoA-S1PR2? No Wa¨lchli et al. (2013)
NogoB-NgBR No Acevedo et al. (2004); Miao et al. (2006); Zhao et al. (2010)
Sonic Hedgehog-Ptch/Smo Yes (exception) Alvarez et al. (2011); Pola et al. (2001)
CNS-Specific Functions in Angiogenesis and Vascular Patterning
Wnt7a/b-(Fzd6) Yes Daneman et al. (2009); Liebner et al. (2008); Stenman et al. (2008)
Norrin-Fzd4 Maintenance Wang et al. (2012); Ye et al. (2009)
Unknown ligand-GPR124 Yes Anderson et al. (2011); Cullen et al. (2011); Kuhnert et al. (2010)
Unknown ligand-DR6/TROY Yes Tam et al. (2012)
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volved in blood-retinal-barrier (BRB) and BBB maintenance in
different brain regions, a function that was suggested to depend
on Norrin-mediated endothelial cell-mural cell interactions (Ye
et al., 2009).
Frizzled4 was shown to be important for the maintenance of
barrier function cell autonomously (Wang et al., 2012) and this
function was not restricted to the retina but revealed its effect
in different CNS regions including the cerebellum, the olfactory
bulb and the spinal cord (Table 4). However, other CNS regions
such as cerebral cortex, striatum, and thalamus showed no
BBB defects in Frizzled4/ mice (Wang et al., 2012). Thus,
although endothelial Frizzled4 is expressed in various CNS re-
gions (Wang et al., 2012; Ye et al., 2009), Frizzled4/ shows
angiogenesis and barriergenesis defects only in certain CNS re-
gions, but how this interesting region specificity is established
molecularly is not clear to date. Frizzled4 is also expressed on
non-CNS endothelial cells (Wang et al., 2012; Ye et al., 2009),
but its functional relevance on angiogenesis outside the CNS is
unknown.
In summary, Wnt/b-catenin signaling is required for appro-
priate, CNS-specific and compartment-specific angiogenesis
and is necessary for the establishment and differentiation of
the BBB in vivo (Daneman et al., 2009; Stenman et al., 2008)
and in vitro (Liebner et al., 2008) (Table 4; Table S4). The Wnt li-
gands and receptors thereby act as (short range) molecular cues
expressed within the CNS parenchyma influencing the migration
and differentiation of the invading endothelial sprouts thereby
tightly coupling the regulation of CNS angiogenesis and barrier-genesis, in accordance with the hypothesis formulated earlier
(Stewart and Wiley, 1981).
Interestingly, Wnt/b-catenin signaling interacts with the VEGF-
VEGFR-Dll4-Jagged-Notch pathway (Corada et al., 2010; Phng
et al., 2009). Wnt/b-catenin upregulates Dll4-Notch signaling
in vivo and in vitro, leading to defects in vascular branching
and loss of venous identity in mouse and zebrafish (Corada
et al., 2010). Furthermore, the Notch downstream target
Notch-regulated ankyrin repeat protein (Nrarp) regulates Wnt
and Notch signaling in stalk cells (Phng et al., 2009). All these
effects were described in mouse retina andmouse and zebrafish
ISVs and thus revealed no CNS specificity. In contrast to the
CNS-specific effects of Wnt7a/7b described above, the involved
ligands and receptors were not investigated here thereby sug-
gesting that some Wnt ligands and receptors act as CNS-spe-
cific angiogenic cues, whereas others act as general cues for
angiogenesis.
DR6 and TROY Receptors in Angiogenesis
Tumor necrosis factor receptor superfamily member 21
(TNFFRSF21) also known as Death receptor 6 (DR6) and Tumor
necrosis factor receptor superfamily member 19 (TNFRSF19
also known as TROY) are death receptors belonging to the tumor
necrosis factor (TNF) receptor family that are expressed in neu-
rons and have been involved in axonal pruning and neuron death
(Nikolaev et al., 2009). DR6 and TROY are CNS-specific regula-
tors of angiogenesis and barriergenesis (Figures 4A and 4B;
Tables 3 and 4; Table S4). In the zebrafish, DR6 is expressed
in blood vessels in the brain but not in ISVs at 3 dpf, andmorpho-
lino-mediated knockdown of DR6 and TROY led to defects inNeuron 87, July 15, 2015 ª2015 Elsevier Inc. 287
Neuron
Reviewvessel arborization selectively in the brain. These CNS-specific
angiogenesis defects were characterized by a reduced vessel
number, length, and thus decreased vessel density of hindbrain
central arteries (CtA) at 3 dpf, suggesting that DR6 and TROY are
required for the initial sprouting of the CtA vessels (Tam et al.,
2012).
During mouse development (E14.5, P7.5), DR6 and TROY are
highly expressed in the mouse CNS (cortex) vasculature as
compared to the non-CNS vasculature of the liver and the lung
(Tam et al., 2012). At the functional level, DR6 global- or endothe-
lial-specific conditional knockout mice showed reduced vessel
density in E14.5 and adult brains, and in vitro sprouting of
HBMECs is decreased after siRNA-mediated knockdown of
DR6 or TROY (Tam et al., 2012). Thus, DR6 and TROY regulate
CNS-specific angiogenesis mainly via regulation of sprouting
angiogenesis but not vessel regression, vessel anastomosis, or
lumen formation in vivo (Tam et al., 2012).
Mechanistically, DR6 and TROY have been shown to activate
JNK signaling (Eby et al., 2000), and VEGF-mediated ERK and
subsequent JNK activation is involved in sprouting angiogenesis
in HUVECs (Uchida et al., 2008) (Figure 4B). Knockdown of DR6
or TROY in HBMECs reduced VEGF-mediated JNK signaling
and resulted in decreased HBMECs sprouting (Tam et al.,
2012) (Figure 4B; Table 2). Whether these DR6/TROY-VEGF-A
interactions are also relevant for the in vivo regulation of CNS
angiogenesis remains elusive.
Similar to Wnt7a/7b, DR6 also regulates barriergenesis (Tam
et al., 2012) (Table 4): DR6 global- or endothelial-specific condi-
tional knockout mice showed forebrain-specific hemorrhages (at
E11.5) and increased leakage of transcardially perfused sulfo-
NHS-biotin across the BBB at E18.5, while in the adult mouse
brain, DR6 or TROY knockout increased BBB leakage assessed
by Evans blue extravasation (Tam et al., 2012). The zebrafish has
recently been shown to have a functional BBB from early devel-
opment on (3 dpf) (Jeong et al., 2008). DR6 and TROYmorphants
showed leakage of cells (DAPI) and injected tracers (rhodamine-
dextran) across the BBB due to BBB perturbation (Tam et al.,
2012).
Based on the similar functions of DR6 and TROY, these two re-
ceptors seem to have synergistic effects on the CNS vasculature
and physically and genetically interact to form a functional re-
ceptor complex important for CNS angiogenesis and barriergen-
esis in zebrafish (Tam et al., 2012).
In conclusion, in zebrafish and mouse, DR6 and TROY recep-
tors are essential for proper CNS angiogenesis and barriergene-
sis but not for angiogenesis outside the CNS (Table 3; Table S4).
Interestingly, in HBMECs, Wnt3a stimulation or increased
beta-catenin levels lead to upregulation of DR6 and TROY
mRNA (Tam et al., 2012), whereas in DR6 knockout mice, Wnt
expression is attenuated in mouse brain vasculature but not in
the vasculature of the lung or the liver (Tam et al., 2012). Accord-
ingly, the authors propose a model in which DR6 and TROY are
downstream targets of the Wnt/b-catenin signaling in CNS (but
not non-CNS) endothelial cells highlighting an interesting cross-
talk of two CNS-specific angiogenic cues. Following this model,
neuroepithelium-derived Wnt ligand secretion stimulates DR6
and TROY expression on CNS endothelial cells. Subsequently,
DR6 and TROY reinforce endothelial Wnt/b-catenin signaling to288 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.activate JNK signaling thereby regulating angiogenesis via a
JNK-mediated crosstalk with the VEGF-A/VEGFR2 pathway
(Tam et al., 2012) (Figure 4B). The precise molecular mecha-
nisms regulating CNS-specific angiogenesis and barriergenesis
remain, however, elusive.
GPR124 Receptor in Angiogenesis
The orphan G protein-coupled receptor 124 (GPR124), also
known as tumor endothelial marker 5 (TEM5), is highly ex-
pressed on endothelial cells and pericytes in the brain, the spinal
cord, and the PNVP (Anderson et al., 2011; Cullen et al., 2011;
Kuhnert et al., 2010) and expressed at much lower levels on
non-CNS endothelial cells of the liver, heart, and kidney during
embryonic mouse development at E10.5–E15.5 (Anderson
et al., 2011; Cullen et al., 2011; Kuhnert et al., 2010). Notably,
the same expression pattern is seen in endothelial cells and
pericytes from human fetal brain tissue (Cullen et al., 2011).
GPR124 global- and endothelial-specific knockout induced
CNS-specific vascular patterning defects and was embryonic
lethal at E14.5 (Cullen et al., 2011; Kuhnert et al., 2010). These
patterning defects were restricted to the forebrain and ventral
neural tube, thereby revealing region specificities similar to
Wnt and DR6/TROY. Moreover, forebrain vessels from the
PNVP did not invade the CNS tissue but showed a PNVP thick-
ening (Anderson et al., 2011; Kuhnert et al., 2010), reminiscent of
Wnt7a/b double knockout phenotype described above (Dane-
man et al., 2009; Stenman et al., 2008). Accordingly, migration
of CNS endothelial cells to the subventricular zone (SVZ) was
delayed and CNS endothelial tip cell filopodial extensions
were severely disturbed (Cullen et al., 2011; Kuhnert et al.,
2010), resulting in an almost avascular telencephalon, with the
formation of basally localized glomeruloid vascular malforma-
tions consisting of multiple layers of endothelial cells and subse-
quent hemorrhages into the forebrain and along the ventral
spinal cord (Cullen et al., 2011; Kuhnert et al., 2010). As these
vascular malformations showed normal pericyte recruitment
and radial glia development (Anderson et al., 2011; Cullen
et al., 2011), the mechanisms underlying the formation of these
vascular glomeruloid tufts (vascular malformations) are currently
not known (Anderson et al., 2011).
Strikingly, GPR124/ did not alter sprouting angiogenesis
into other regions of the embryonic CNS (e.g., diencephalon,
midbrain, and hindbrain) or the vascularization in non-CNS tis-
sues (heart, liver, intestine, and lung) at E12.5 (Anderson et al.,
2011; Kuhnert et al., 2010), underlining the CNS-specific and
compartment-specific effects of this molecule on angiogenesis
(Figures 4A and 4B; Table 3; Table S4).
The CNS-specific mode of action was further illustrated as
endothelial overexpression of GPR124 led to localized areas of
hypervascularity mainly in the cortex and less frequently in the
cerebellum in the adult mice (Kuhnert et al., 2010). In those ani-
mals, (micro-) vascular density was increased and abundant
vascular malformations characterized by tortuous, thin-walled,
and enlarged vessels were found (Kuhnert et al., 2010). Strik-
ingly, overexpression of GPR124 in the endothelium of non-
CNS organs such as the heart and the liver (which do normally
not express GPR124) had no effect on vascular development
(Kuhnert et al., 2010). It is tempting to speculate that the inability
of GPR124 to affect non-CNS vasculature is due to the lack of
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environment in the CNS.
The GPR124-expressing brain endothelial cell line bEND3
(Kuhnert et al., 2010) shows a directed migration toward gradi-
ents of conditioned medium from E12.5 forebrain but not
hindbrain extracts (Kuhnert et al., 2010). Small interfering RNA-
mediated knockdown of GPR124 abolished directed migration
(Kuhnert et al., 2010), while blocking the VEGF-pathway with a
recombinant soluble VEGFR1 ectodomain did not, suggesting
a VEGF-independent mechanism (Kuhnert et al., 2010) (Fig-
ure 4B; Table 2). Similar results were seen for bEND3 sprouting
and lumen formation (Kuhnert et al., 2010).
Mechanistically, the pro-angiogenic effect of GPR124 on
directed migration is Cdc42 dependent but VEGFR2/Nrp-1
independent (Kuhnert et al., 2010) (Figure 4B; Table 2). In
line with these in vitro data, expression of the vascular recep-
tors VEGFR2, VEGFR3, Nrp-1, and Endoglin (a TGF-b co-
receptor) were not altered in GPR124/ embryos (Anderson
et al., 2011; Kuhnert et al., 2010). However, Cullen et al. found
that VEGF-A (and mainly its isoform VEGF164) was signifi-
cantly upregulated in E11.5 GPR124/ embryos. Given these
observations, whether and how the GPR124-induced signaling
pathway crosstalks with the VEGF-pathway needs further
investigation.
In addition to these CNS-specific effects on angiogenesis,
GPR124 also regulates the formation and differentiation of the
BBB, again similar to the Wnt/b-catenin and DR6/TROY
signaling pathways (Anderson et al., 2011; Cullen et al., 2011;
Kuhnert et al., 2010) (Table 1). Expression of Glut1, an important
marker for endothelial specialization and BBB formation (Engel-
hardt, 2003), was absent on vessels in E12.5/E13.5 global- or
vascular-specific GPR124/mice (Anderson et al., 2011; Cullen
et al., 2011; Kuhnert et al., 2010), suggesting impaired BBB
formation. Indeed, the vascular glomeruloid malformations
were surrounded by accumulations of extravascular fibrin,
thereby indicating a BBB leakage (Cullen et al., 2011). In
E18.5 GPR124/ animals, intracardially injected biotin passed
through the leaky blood-brain barrier into the brain parenchyma,
whereas non-CNS vessels showed no permeability defects.
Intriguingly, these barrier defects were again regionally restricted
with leakage into the forebrain and ventral spinal cord but not
into other CNS regions (Cullen et al., 2011). GPR124’s regulatory
role on BBB properties is further confirmed in vitro, where over-
expression of GPR124 in bEnd3s enhances barrier properties
(Cullen et al., 2011).
In conclusion, GPR-124 is important for angiogenic sprouting
and barriergenesis in themouse forebrain and ventral spinal cord
in a highly CNS-specific and compartment-specific manner
(Anderson et al., 2011; Cullen et al., 2011; Kuhnert et al., 2010).
Interestingly, these findings are very similar to what has been
described for the Wnt7/b-catenin signaling axis (Daneman
et al., 2009; Stenman et al., 2008) and for the DR6/TROY recep-
tors (Tam et al., 2012), thus revealing striking common features
of CNS-specific angiogenic cues (Table S4).
Taken together, these observations suggest that the same
molecular cues that are CNS-specific regulators of angiogenesis
also regulate the differentiation and formation of the BBB,
thereby representing examples of the CNS-derived instructivecues predicted by Stewart and Wiley (Stewart and Wiley, 1981)
(see Table 4; Figure 4A).
Outlook
Over the last decade, our understanding of how the vascular
network of tissues and organs is established has significantly
increased, especially with regard to the process of sprouting
angiogenesis (Carmeliet and Jain, 2011; Potente et al., 2011;
Wacker and Gerhardt, 2011). In parallel, molecular interactions
between the nervous and the vascular system are increasingly
discovered (Eichmann and Thomas, 2013; Quaegebeur et al.,
2011) and thereby contribute to our understanding of angiogen-
esis and the neurovascular link.
However, several outstanding questions regarding the molec-
ular basis of vascular morphogenesis and the nature of neuro-
vascular interactions remain unanswered. (1) How abundant
are CNS-specific and general cues and how do they interact
molecularly to govern CNS angiogenesis in health and disease?
(2) How comparable are the mechanisms governing angiogen-
esis during development and in pathology models such as
tumors or ischemic conditions? (3) How strong is the molecular
link betweenCNS angiogenesis and barriergenesis and are there
cues that only regulate barriergenesis? (4) Do most of the angio-
genic cues in angiogenesis in- and outside the CNS interfere with
the canonical VEGF pathway and, if yes, at which level? More-
over, how important are VEGF-independent pathways and how
do these pathways correlate with the mechanisms of vascular
development in different organ systems? (5) Given the current
focus on sprouting angiogenesis, how important are other
modes of vessel formation, how do they differ between distinct
vascular beds, and how are they regulated molecularly? (6)
Finally, is a co-patterning of vessels and nerves also apparent
in the CNS?
CNS-Specific and General Mechanisms of Angiogenesis
HowAbundant Are CNS-Specific and General Cues and HowDo
They Interact Molecularly to Govern CNS Angiogenesis in Health
and Disease? As highlighted in this Review, one central question
is whether a protein regulates angiogenesis in a general (e.g.,
non-organ specific) or in an organ-specific manner (Figure 4),
with effects restricted to one or only some organs and tissue
beds. This aspect is especially interesting in the CNS with its
highly specialized vasculature (Figure 3). Notably, the presently
known CNS-specific cues for angiogenesis additionally display
remarkable region-specific effects within the CNS (e.g., between
hind- and forebrain) (Daneman et al., 2009; Kuhnert et al., 2010;
Stenman et al., 2008; Tam et al., 2012; Vasudevan et al., 2008)
(Table 1). This is a very interesting finding in light of the highly
regionalized functions of the brain (deCharms, 2008). As
described in this Review, classical molecules regulating nerve-
and vessel morphogenesis such as Netrins and Semaphorins,
as well as Nogo proteins regulate angiogenesis in various tissues
including the CNS. Only recently, CNS-specific regulators of
vascular development such as Wnt7a/b, DR6/TROY, and
GRP124 have been discovered. In order to address these ques-
tions of CNS-specific angiogenesis more systematically, we
propose a novel conceptual framework for future studies: for
instance, the effects of certain gene knockouts on in vivo
angiogenesis should be studied in CNS (brain and retina) andNeuron 87, July 15, 2015 ª2015 Elsevier Inc. 289
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pressed). Moreover, corresponding in vitro studies should use
isolated endothelial cells from the organ studied in vivo when-
ever possible.
How Comparable Are the Mechanisms Governing Angiogen-
esis during Development and in Pathology Models Such as
Tumors or Ischemic Conditions? Organ and tissue specificity
could also provide opportunities for selective vascular targeting
in CNS pathologies involving angiogenesis such as brain tumors
or stroke. The rationale for drug development that targets neo-
angiogenesis in pathology is classically based on exploiting the
differing molecular signature and status of the quiescent endo-
thelium present in most healthy organs in the adult and of the
activated endothelium where new vessel growth occurs (Carme-
liet and Jain, 2011; Jain and Carmeliet, 2012). However, the
emerging insights into the profound heterogeneity of the endo-
thelium (Herbert and Stainier, 2011; Nolan et al., 2013) raises
the prospect of identifying selective cell-surface targets and
signaling pathways that act specifically within the organs and
vascular beds affected by the pathology. Such selective target-
ing may increase efficacy and minimize unwanted side effects,
for example, on the vasculature of the surrounding CNS paren-
chyma and/or of peripheral organs.
Moreover, interacting with an angioneurin-related pathway
always has the potential danger of affecting not only the targeted
system (i.e., the vascular) but also the related system (i.e., the
nervous system). This is, for instance, illustrated by the recent
finding that glioblastoma patients treated with the anti-VEGF-A
antibody bevacizumab (Avastin, Roche) may have a higher inci-
dence of dementia than the control group (AVAglio study, 2013,
ASCO, abstract), even though the molecular mechanisms
responsible for this finding remain obscure (direct effect on neu-
rons versus effect on endothelial cells outside the tumor region).
Therefore, the differences in expression patterns of angiogenic
ligand-receptor pairs between organs and between pathological
and physiological tissue is of outstanding importance. Targeting,
e.g., vascular-specific receptors such as Unc5b (Larrive´e et al.,
2007; Lu et al., 2004), Robo4 (Jones et al., 2008, 2009), or
NgBR (Miao et al., 2006) or tissue-specific receptors such as
GPR124 (Anderson et al., 2011; Cullen et al., 2011; Kuhnert
et al., 2010) or DR6/TROY (Tam et al., 2012) may allow to mini-
mize those side effects.
CNS-Specific Angiogenesis and Barriergenesis
How Strong Is the Molecular Link between CNS Angiogenesis
and Barriergenesis and Are There Cues that Only Regulate Bar-
riergenesis? As outlined above, CNS-specific cues also act on
the formation and differentiation of the BBB, whereas general
cues for angiogenesis do not (Figure 4A; Table 1). Intriguingly,
CNS angiogenesis and barriergenesis are regulated by the
same CNS-specific cues and hence are tightly linked. Given
that the processes of CNS sprouting angiogenesis and endothe-
lial tip cell biology on the one and of barriergenesis on the other
hand are quite different, the observation that they are regulated
by at least some common signaling pathways is very interesting.
Notably, some general angiogenic cues such as VEGF-A,
Semaphorin-3A, Semaphorin-3F, and Semaphorin-7A, Netrin-1,
and Netrin-4 as well as Slit2-Robo4 affect BBB maintenance by
increasing vascular permeability (Figures 4A and 4B; Table 1).290 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.Despite this modulation of BBB physiology, these molecules
are—in contrast to the above-described CNS-specific angio-
genic cues—not involved in barriergenesis or BBB differentia-
tion. The exception to this rule seems to be the Sonic hedgehog
pathway, which is known to be important for various aspects of
brain development and function (e.g., axonal guidance or adult
hippocampal neurogenesis) (Ferent and Traiffort, 2014). Sonic
hedgehog affects angiogenesis in a non-CNS specific manner
but—in contrast to the other non-CNS specific cues—also bar-
riergenesis (Alvarez et al., 2011; Nagase et al., 2008).
Based on these concepts and given the predominant role of
VEGF and its receptors on angiogenesis (Carmeliet and Jain,
2011; Potente et al., 2011), it seems likely that tissue vasculariza-
tion is achieved by a combination of VEGF, general-, and organ-
specific cues for angiogenesis.
A combination of general and tissue-specific cues is also at
work in other examples of highly specialized vasculature. The
blood vessels of the kidney glomeruli and the liver sinusoids,
for instance, are lined by specialized, fenestrated endothelial
cells (Rocha and Adams, 2009). This vascular bed-specific,
fenestrated endothelial cell phenotype is generated by a combi-
nation of VEGF-A and the organ-specific factor plasmalemmal
vesicle-associated protein-1 (PV-1 also known as PLVAP) (Ro-
cha and Adams, 2009). In the peripheral nervous system, the
nerve-blood barrier is established (Weerasuriya and Mizisin,
2011) and is—although similar to the BBB—less tight with regard
to the cell-cell connections. It would therefore be interesting
to understand whether different cues regulate barrier formation
in peripheral nerves as compared to CNS angiogenesis and
barriergenesis.
Interaction with the VEGF-VEGFR-Dll4-Jagged-Notch
Pathway
How Important Are VEGF-Independent Pathways and How Do
These Pathways Correlate with the Mechanisms of Vascular
Development in Different Organ Systems? At themolecular level,
one outstanding question is whether and how the general and
CNS-specific cues for angiogenesis interact with the VEGF-
VEGFR-Dll4-Jagged-Notch pathway (Figure 4). Recent findings
suggest that most of the guidance pathways that are shared be-
tween the neural and vascular system, such as Netrin/Unc5b,
Semaphorin/Plexin, Ephrin/Eph, and Slit/Robo, all exert direct
effects on the cytoskeleton but also function in the endothelium
by modulating VEGF-VEGFR signaling (Jones et al., 2008, 2009;
Kim et al., 2011; Koch et al., 2011; Lu et al., 2004; Sawamiphak
et al., 2010b; Wang et al., 2010b; Zygmunt et al., 2011)
(Figure 4B). Conceptually, these observations reinforce the
central role of VEGF-VEGFR signaling, and its feedback mecha-
nisms including Notch, as central pattern generators in angio-
genesis (Blanco and Gerhardt, 2013). However, they also raise
additional questions as to how the endothelial cells, singly or
as a collective, can integrate the disparate inputs into guided
angiogenesis. Moreover, recent evidence indicates that there
is at least the possibility that some CNS-specific cues
(GPR124 [Anderson et al., 2011; Cullen et al., 2011; Kuhnert
et al., 2010], Wnt7a/7b [Daneman et al., 2009; Stenman et al.,
2008] as well as Nogo-A [Wa¨lchli et al., 2013]) may signal inde-
pendently of the VEGF-axis to regulate angiogenesis. Further
work along these lines will reveal whether these pathways are
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another—yet unknown—molecular level. This concept referring
to a central pattern generator for angiogenesis that is modulated
by other angiogenic pathwaysmay emerge as a fundamental dif-
ference to neuronal guidance, where no such concept has been
described so far and where direct signaling to the cytoskeleton
steers the axonal growth cone.
Future work will need to establish whether the moderate clin-
ical success of approaches blocking the VEGF-VEGFR-Dll4-
Jagged-Notch pathway (Carmeliet and Jain, 2011; De Bock
et al., 2011; Hanahan and Weinberg, 2011; Jain and Carmeliet,
2012) can be enhanced, supplemented or surpassed by target-
ing additional modulators or VEGF-independent pathways.
Cellular Interactions in the Neurovascular Unit and
Different Modes of Vessel Formation
Given the Current Focus on Sprouting Angiogenesis, How
Important Are Other Modes of Vessel Formation, How Do They
Differ Between Distinct Vascular Beds, and How Are They Regu-
lated Molecularly? Angiogenesis occurs within a complex micro-
environment composed of endothelial cells, the extracellular
matrix, and the different cell types of the corresponding tissue
(Figure 3). In the CNS, interactions of the endothelium with neu-
rons, neuronal stem cells, astrocytes, oligodendrocytes, myelin,
and pericytes (Hjelmeland et al., 2011; Quaegebeur et al., 2011;
Storkebaum et al., 2011) during embryonic and postnatal devel-
opment are just beginning to be unraveled. Intriguingly, these
cellular interactions can display region-specific differences
even within the CNS as, for instance, highlighted by the recent
finding that BBB properties are altered at the SVZ where dividing
neural stem cells contact vascular endothelial cells at BBB sites
that lack the usually present astrocyte endfeet and pericyte
coverage (Abbott et al., 2006; Tavazoie et al., 2008). This mutual
crosstalk between cells emerges as a central concept also in
pathologies. For instance, glioblastoma stem-like cells have
been suggested to de-differentiate into tumor endothelial cells
(Ricci-Vitiani et al., 2010; Wang et al., 2010a) or into tumor peri-
cytes (Cheng et al., 2013), and endothelial tip cells can activate
metastasis of breast cancers (Ghajar et al., 2013), and these
fascinating yet poorly understood phenomena offer great thera-
peutic potential (Butler et al., 2010; Carmeliet and Jain, 2011;
Herbert and Stainier, 2011; Potente et al., 2011; Quaegebeur
et al., 2011). A more thorough investigation of the influence of
perivascular cells—which significantly differ between organs
including CNS and non-CNS tissues (Quaegebeur et al.,
2011)—on angio- and arteriogenesis—is key for future progress
in developmental and pathological settings.
Besides the current focus on sprouting angiogenesis, other
modes of physiological (vasculogenesis, intussusception) and
pathological blood vessel formation (vascular mimicry, vascular
co-option, differentiation of stem cells into endothelial cells or
into pericytes) (Carmeliet and Jain, 2011; Jain and Carmeliet,
2012; Potente et al., 2011) require further attention.
Co-patterning of Vessels and Nerves in the CNS?
Finally, Is a Co-patterning of Vessels and Nerves Also Apparent
in the CNS? The initial observation of the co-patterning and
alignment of vessels and nerves at different scales in the pe-
riphery has initiated research in the field of the neurovascular
link and has led to the discovery of angioneurins (Carmelietand Tessier-Lavigne, 2005). As highlighted in this Review,
angioneurins affect axonal guidance and angiogenesis also in
the CNS. Axonal guidance cues are known to steer neuronal
growth cones to their appropriate targets by attraction and
repulsion along an expression gradient. For instance, Sema-
phorin-3A shows a graded expression pattern in cortical layers
of the postnatal brain thereby guiding radial migration of pyra-
midal neurons (Chen et al., 2008). On the other hand, a
Netrin-1 gradient in the ganglionic eminence in the embryonic
forebrain (around E14.5–E15.5) is important for the correct pro-
jection of thalamocortical axon tracts (Powell et al., 2008). Inter-
estingly, however, nothing is known about possible effects of
these gradients on late embryonic or postnatal vascular sprout-
ing and vessel density in the CNS. It will therefore be interesting
to investigate how the common molecular cues acting on
axonal growth cones and endothelial tip cells affects the
morphogenesis of nerves and vessels within different compart-
ments of the brain.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four tables and can be found with this
article online at http://dx.doi.org/10.1016/j.neuron.2015.06.038.
AUTHOR CONTRIBUTIONS
T.W. had the idea for the review, wrote the manuscript and made the figures.
A.W. helped with manuscript writing and figure illustration. H.G. and B.E. gave
critical inputs. All authors edited and approved the final manuscript.
ACKNOWLEDGMENTS
We thank Stefan Schwyter for help with illustrations, Jose´ Marı´a Mateos for
support with endothelial tip cell images, and Caroline Coisne and Claudio
Franco for providing images of the BBB and endothelial tip cells of the hind-
brain, respectively. T.W. was supported by a MD-PhD fellowship of the Swiss
National Science Foundation, by the Olga Mayenfisch Foundation, the EMDO
Foundation, the HartmannMu¨ller Foundation, the OPO Foundation, and by the
MD-PhD student allowance of the Swiss Society for Microvascular Research
(SSMVR). T.W. and A.W. were supported by the Baasch-Medicus Foundation,
the Fonds fu¨r Medizinische Forschung, and the Swiss Heart Foundation. H.G.
was supported by an ERC consolidator grant (311719) Reshape. B.E. was sup-
ported by the EU FP7 funded project JUSTBRAIN HEALTH-2009-241861 and
by the Swiss National Science Foundation.
REFERENCES
Abbott, N.J., Ro¨nnba¨ck, L., and Hansson, E. (2006). Astrocyte-endothelial in-
teractions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41–53.
Acevedo, L., Yu, J., Erdjument-Bromage, H., Miao, R.Q., Kim, J.E., Fulton, D.,
Tempst, P., Strittmatter, S.M., and Sessa, W.C. (2004). A new role for Nogo as
a regulator of vascular remodeling. Nat. Med. 10, 382–388.
Acevedo, L.M., Barillas, S., Weis, S.M., Go¨thert, J.R., and Cheresh, D.A.
(2008). Semaphorin 3A suppresses VEGF-mediated angiogenesis yet acts
as a vascular permeability factor. Blood 111, 2674–2680.
Adams, R.H., Wilkinson, G.A., Weiss, C., Diella, F., Gale, N.W., Deutsch, U.,
Risau, W., and Klein, R. (1999). Roles of ephrinB ligands and EphB receptors
in cardiovascular development: demarcation of arterial/venous domains,
vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 13,
295–306.
Alvarez, J.I., Dodelet-Devillers, A., Kebir, H., Ifergan, I., Fabre, P.J., Terouz, S.,
Sabbagh, M., Wosik, K., Bourbonnie`re, L., Bernard, M., et al. (2011). The
Hedgehog pathway promotes blood-brain barrier integrity and CNS immune
quiescence. Science 334, 1727–1731.Neuron 87, July 15, 2015 ª2015 Elsevier Inc. 291
Neuron
ReviewAnderson, K.D., Pan, L., Yang, X.M., Hughes, V.C., Walls, J.R., Dominguez,
M.G., Simmons, M.V., Burfeind, P., Xue, Y., Wei, Y., et al. (2011). Angiogenic
sprouting into neural tissue requires Gpr124, an orphan G protein-coupled re-
ceptor. Proc. Natl. Acad. Sci. USA 108, 2807–2812.
Bareyre, F.M., Haudenschild, B., and Schwab, M.E. (2002). Long-lasting
sprouting and gene expression changes induced by the monoclonal antibody
IN-1 in the adult spinal cord. J. Neurosci. 22, 7097–7110.
Barros, C.S., Franco, S.J., andMu¨ller, U. (2011). Extracellular matrix: functions
in the nervous system. Cold Spring Harb. Perspect. Biol. 3, a005108.
Bates, D., Taylor, G.I., Minichiello, J., Farlie, P., Cichowitz, A., Watson, N.,
Klagsbrun, M., Mamluk, R., and Newgreen, D.F. (2003). Neurovascular
congruence results from a shared patterning mechanism that utilizes
Semaphorin3A and Neuropilin-1. Dev. Biol. 255, 77–98.
Bautch, V.L. (2012). VEGF-directed blood vessel patterning: from cells to
organism. Cold Spring Harb. Perspect. Med. 2, a006452.
Bautch, V.L., and James, J.M. (2009). Neurovascular development: The begin-
ning of a beautiful friendship. Cell Adhes. Migr. 3, 199–204.
Bedell, V.M., Yeo, S.Y., Park, K.W., Chung, J., Seth, P., Shivalingappa, V.,
Zhao, J., Obara, T., Sukhatme, V.P., Drummond, I.A., et al. (2005).
roundabout4 is essential for angiogenesis in vivo. Proc. Natl. Acad. Sci. USA
102, 6373–6378.
Blanco, R., and Gerhardt, H. (2013). VEGF and Notch in tip and stalk cell selec-
tion. Cold Spring Harb. Perspect. Med. 3, a006569.
Bouvre´e, K., Larrive´e, B., Lv, X., Yuan, L., DeLafarge, B., Freitas, C., Mathivet,
T., Bre´ant, C., Tessier-Lavigne, M., Bikfalvi, A., et al. (2008). Netrin-1 inhibits
sprouting angiogenesis in developing avian embryos. Dev. Biol. 318, 172–183.
Bussmann, J.,Wolfe, S.A., and Siekmann, A.F. (2011). Arterial-venous network
formation during brain vascularization involves hemodynamic regulation of
chemokine signaling. Development 138, 1717–1726.
Butler, J.M., Kobayashi, H., and Rafii, S. (2010). Instructive role of the vascular
niche in promoting tumour growth and tissue repair by angiocrine factors. Nat.
Rev. Cancer 10, 138–146.
Capparuccia, L., and Tamagnone, L. (2009). Semaphorin signaling in cancer
cells and in cells of the tumor microenvironment—two sides of a coin. J. Cell
Sci. 122, 1723–1736.
Carmeliet, P., and Jain, R.K. (2011). Molecular mechanisms and clinical appli-
cations of angiogenesis. Nature 473, 298–307.
Carmeliet, P., and Tessier-Lavigne, M. (2005). Common mechanisms of nerve
and blood vessel wiring. Nature 436, 193–200.
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein,
M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996).
Abnormal blood vessel development and lethality in embryos lacking a single
VEGF allele. Nature 380, 435–439.
Castets, M., and Mehlen, P. (2010). Netrin-1 role in angiogenesis: to be or not
to be a pro-angiogenic factor? Cell Cycle 9, 1466–1471.
Cerani, A., Tetreault, N., Menard, C., Lapalme, E., Patel, C., Sitaras, N., Beau-
doin, F., Leboeuf, D., De Guire, V., Binet, F., et al. (2013). Neuron-derived
semaphorin 3A is an early inducer of vascular permeability in diabetic retinop-
athy via neuropilin-1. Cell Metab. 18, 505–518.
Charron, F., and Tessier-Lavigne, M. (2007). The Hedgehog, TGF-beta/BMP
and Wnt families of morphogens in axon guidance. Adv. Exp. Med. Biol.
621, 116–133.
Chen, G., Sima, J., Jin, M., Wang, K.Y., Xue, X.J., Zheng, W., Ding, Y.Q., and
Yuan, X.B. (2008). Semaphorin-3A guides radial migration of cortical neurons
during development. Nat. Neurosci. 11, 36–44.
Cheng, L., Huang, Z., Zhou, W., Wu, Q., Donnola, S., Liu, J.K., Fang, X., Sloan,
A.E., Mao, Y., Lathia, J.D., et al. (2013). Glioblastoma stem cells generate
vascular pericytes to support vessel function and tumor growth. Cell 153,
139–152.
Coma, S., Shimizu, A., and Klagsbrun, M. (2011). Hypoxia induces tumor and
endothelial cell migration in a semaphorin 3F- and VEGF-dependent manner292 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.via transcriptional repression of their common receptor neuropilin 2. Cell
Adhes. Migr. 5, 266–275.
Corada, M., Nyqvist, D., Orsenigo, F., Caprini, A., Giampietro, C., Taketo,
M.M., Iruela-Arispe, M.L., Adams, R.H., and Dejana, E. (2010). The Wnt/
beta-catenin pathway modulates vascular remodeling and specification by
upregulating Dll4/Notch signaling. Dev. Cell 18, 938–949.
Cullen, M., Elzarrad, M.K., Seaman, S., Zudaire, E., Stevens, J., Yang, M.Y., Li,
X., Chaudhary, A., Xu, L., Hilton, M.B., et al. (2011). GPR124, an orphan G
protein-coupled receptor, is required for CNS-specific vascularization and
establishment of the blood-brain barrier. Proc. Natl. Acad. Sci. USA 108,
5759–5764.
Daneman, R., Agalliu, D., Zhou, L., Kuhnert, F., Kuo, C.J., and Barres, B.A.
(2009). Wnt/beta-catenin signaling is required for CNS, but not non-CNS,
angiogenesis. Proc. Natl. Acad. Sci. USA 106, 641–646.
Daneman, R., Zhou, L., Kebede, A.A., and Barres, B.A. (2010). Pericytes are
required for blood-brain barrier integrity during embryogenesis. Nature 468,
562–566.
De Bock, K., Mazzone, M., and Carmeliet, P. (2011). Antiangiogenic therapy,
hypoxia, and metastasis: risky liaisons, or not? Nat. Rev. Clin. Oncol. 8,
393–404.
de Castro, F., Lo´pez-Mascaraque, L., and De Carlos, J.A. (2007). Cajal: les-
sons on brain development. Brain Res. Brain Res. Rev. 55, 481–489.
De Smet, F., Segura, I., De Bock, K., Hohensinner, P.J., and Carmeliet, P.
(2009). Mechanisms of vessel branching: filopodia on endothelial tip cells
lead the way. Arterioscler. Thromb. Vasc. Biol. 29, 639–649.
deCharms, R.C. (2008). Applications of real-time fMRI. Nat. Rev. Neurosci. 9,
720–729.
Dickson, B.J. (2002). Molecular mechanisms of axon guidance. Science 298,
1959–1964.
Eby, M.T., Jasmin, A., Kumar, A., Sharma, K., and Chaudhary, P.M. (2000).
TAJ, a novel member of the tumor necrosis factor receptor family, activates
the c-Jun N-terminal kinase pathway and mediates caspase-independent
cell death. J. Biol. Chem. 275, 15336–15342.
Eichmann, A., and Thomas, J.L. (2013). Molecular parallels between neural
and vascular development. Cold Spring Harb. Perspec.t Med. 3, a006551.
Ellertsdo´ttir, E., Lenard, A., Blum, Y., Krudewig, A., Herwig, L., Affolter, M., and
Belting, H.G. (2010). Vascular morphogenesis in the zebrafish embryo. Dev.
Biol. 341, 56–65.
Engelhardt, B. (2003). Development of the blood-brain barrier. Cell Tissue Res.
314, 119–129.
Estrach, S., Cailleteau, L., Franco, C.A., Gerhardt, H., Stefani, C., Lemichez, E.,
Gagnoux-Palacios, L., Meneguzzi, G., andMettouchi, A. (2011). Laminin-bind-
ing integrins induce Dll4 expression and Notch signaling in endothelial cells.
Circ. Res. 109, 172–182.
Fantin, A., Vieira, J.M., Plein, A., Denti, L., Fruttiger, M., Pollard, J.W., and
Ruhrberg, C. (2013a). NRP1 acts cell autonomously in endothelium to promote
tip cell function during sprouting angiogenesis. Blood 121, 2352–2362.
Fantin, A., Vieira, J.M., Plein, A., Maden, C.H., and Ruhrberg, C. (2013b). The
embryonic mouse hindbrain as a qualitative and quantitative model for study-
ing the molecular and cellular mechanisms of angiogenesis. Nat. Protoc. 8,
418–429.
Ferent, J., and Traiffort, E. (2014). Hedgehog: multiple paths for multiple roles
in shaping the brain and spinal cord. Neuroscientist. Published online May 8,
2014. http://dx.doi.org/10.1177/1073858414531457.
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O’Shea, K.S.,
Powell-Braxton, L., Hillan, K.J., and Moore, M.W. (1996). Heterozygous em-
bryonic lethality induced by targeted inactivation of the VEGF gene. Nature
380, 439–442.
Fiore, R., Rahim, B., Christoffels, V.M., Moorman, A.F., and Pu¨schel, A.W.
(2005). Inactivation of the Sema5a gene results in embryonic lethality and
defective remodeling of the cranial vascular system. Mol. Cell. Biol. 25,
2310–2319.
Neuron
ReviewFischer, R.S., Gardel, M., Ma, X., Adelstein, R.S., and Waterman, C.M. (2009).
Local cortical tension by myosin II guides 3D endothelial cell branching. Curr.
Biol. 19, 260–265.
Fraccaroli, A., Franco, C.A., Rognoni, E., Neto, F., Rehberg, M., Aszodi, A.,
Wedlich-So¨ldner, R., Pohl, U., Gerhardt, H., and Montanez, E. (2012). Visuali-
zation of endothelial actin cytoskeleton in the mouse retina. PLoS ONE 7,
e47488.
Fukushima, Y., Okada, M., Kataoka, H., Hirashima, M., Yoshida, Y., Mann, F.,
Gomi, F., Nishida, K., Nishikawa, S., and Uemura, A. (2011). Sema3E-PlexinD1
signaling selectively suppresses disoriented angiogenesis in ischemic retinop-
athy in mice. J. Clin. Invest. 121, 1974–1985.
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A., Abrams-
son, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D., and Betsholtz, C. (2003).
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell
Biol. 161, 1163–1177.
Gerhardt, H., Ruhrberg, C., Abramsson, A., Fujisawa, H., Shima, D., and Bet-
sholtz, C. (2004). Neuropilin-1 is required for endothelial tip cell guidance in the
developing central nervous system. Dev. Dyn. 231, 503–509.
Germain, S., Monnot, C., Muller, L., and Eichmann, A. (2010). Hypoxia-driven
angiogenesis: role of tip cells and extracellular matrix scaffolding. Curr. Opin.
Hematol. 17, 245–251.
Geudens, I., and Gerhardt, H. (2011). Coordinating cell behaviour during blood
vessel formation. Development 138, 4569–4583.
Ghajar, C.M., Peinado, H., Mori, H., Matei, I.R., Evason, K.J., Brazier, H.,
Almeida, D., Koller, A., Hajjar, K.A., Stainier, D.Y., et al. (2013). The perivascular
niche regulates breast tumour dormancy. Nat. Cell Biol. 15, 807–817.
Gu, C., Yoshida, Y., Livet, J., Reimert, D.V., Mann, F., Merte, J., Henderson,
C.E., Jessell, T.M., Kolodkin, A.L., and Ginty, D.D. (2005). Semaphorin 3E
and plexin-D1 control vascular pattern independently of neuropilins. Science
307, 265–268.
Hanahan, D., and Weinberg, R.A. (2011). Hallmarks of cancer: the next gener-
ation. Cell 144, 646–674.
Harb, R., Whiteus, C., Freitas, C., and Grutzendler, J. (2013). In vivo imaging of
cerebral microvascular plasticity from birth to death. J. Cereb. Blood Flow
Metab. 33, 146–156.
Herbert, S.P., and Stainier, D.Y. (2011). Molecular control of endothelial cell
behaviour during blood vessel morphogenesis. Nat. Rev. Mol. Cell Biol. 12,
551–564.
Hjelmeland, A.B., Lathia, J.D., Sathornsumetee, S., and Rich, J.N. (2011).
Twisted tango: brain tumor neurovascular interactions. Nat. Neurosci. 14,
1375–1381.
Hoang, S., Liauw, J., Choi, M., Choi, M., Guzman, R.G., and Steinberg, G.K.
(2009). Netrin-4 enhances angiogenesis and neurologic outcome after cere-
bral ischemia. J. Cereb. Blood Flow Metab. 29, 385–397.
Hogan, K.A., Ambler, C.A., Chapman, D.L., and Bautch, V.L. (2004). The neural
tube patterns vessels developmentally using the VEGF signaling pathway.
Development 131, 1503–1513.
Honma, Y., Araki, T., Gianino, S., Bruce, A., Heuckeroth, R., Johnson, E., and
Milbrandt, J. (2002). Artemin is a vascular-derived neurotropic factor for devel-
oping sympathetic neurons. Neuron 35, 267–282.
Jain, R.K., and Carmeliet, P. (2012). SnapShot: Tumor angiogenesis. Cell 149,
1408–1408.e1.
Jakobsson, L., Franco, C.A., Bentley, K., Collins, R.T., Ponsioen, B., Aspalter,
I.M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A., et al. (2010). Endo-
thelial cells dynamically compete for the tip cell position during angiogenic
sprouting. Nat. Cell Biol. 12, 943–953.
James, J.M., Gewolb, C., and Bautch, V.L. (2009). Neurovascular develop-
ment uses VEGF-A signaling to regulate blood vessel ingression into the neural
tube. Development 136, 833–841.
Jeansson, M., Gawlik, A., Anderson, G., Li, C., Kerjaschki, D., Henkelman, M.,
and Quaggin, S.E. (2011). Angiopoietin-1 is essential in mouse vasculature
during development and in response to injury. J. Clin. Invest. 121, 2278–2289.Jeong, J.Y., Kwon, H.B., Ahn, J.C., Kang, D., Kwon, S.H., Park, J.A., and Kim,
K.W. (2008). Functional and developmental analysis of the blood-brain barrier
in zebrafish. Brain Res. Bull. 75, 619–628.
Jones, C.A., London, N.R., Chen, H., Park, K.W., Sauvaget, D., Stockton, R.A.,
Wythe, J.D., Suh, W., Larrieu-Lahargue, F., Mukouyama, Y.S., et al. (2008).
Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis
and endothelial hyperpermeability. Nat. Med. 14, 448–453.
Jones, C.A., Nishiya, N., London, N.R., Zhu, W., Sorensen, L.K., Chan, A.C.,
Lim, C.J., Chen, H., Zhang, Q., Schultz, P.G., et al. (2009). Slit2-Robo4 signal-
ling promotes vascular stability by blocking Arf6 activity. Nat. Cell Biol. 11,
1325–1331.
Joset, P., Wacker, A., Babey, R., Ingold, E.A., Andermatt, I., Stoeckli, E.T., and
Gesemann, M. (2011). Rostral growth of commissural axons requires the cell
adhesion molecule MDGA2. Neural Dev. 6, 22.
Kempf, A., Montani, L., Petrinovic, M.M., Schroeter, A., Weinmann, O., Patrig-
nani, A., and Schwab,M.E. (2013). Upregulation of axon guidancemolecules in
the adult central nervous system of Nogo-A knockout mice restricts neuronal
growth and regeneration. Eur. J. Neurosci. 38, 3567–3579.
Kempf, A., Tews, B., Arzt, M.E., Weinmann, O., Obermair, F.J., Pernet, V.,
Zagrebelsky, M., Delekate, A., Iobbi, C., Zemmar, A., et al. (2014). The sphin-
golipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity.
PLoS Biol. 12, e1001763.
Kim, J., Oh, W.J., Gaiano, N., Yoshida, Y., and Gu, C. (2011). Semaphorin 3E-
Plexin-D1 signaling regulates VEGF function in developmental angiogenesis
via a feedback mechanism. Genes Dev. 25, 1399–1411.
Koch, A.W., Mathivet, T., Larrive´e, B., Tong, R.K., Kowalski, J., Pibouin-
Fragner, L., Bouvre´e, K., Stawicki, S., Nicholes, K., Rathore, N., et al. (2011).
Robo4 maintains vessel integrity and inhibits angiogenesis by interacting
with UNC5B. Dev. Cell 20, 33–46.
Kritz, A.B., Yu, J., Wright, P.L., Wan, S., George, S.J., Halliday, C., Kang, N.,
Sessa, W.C., and Baker, A.H. (2008). In vivo modulation of Nogo-B attenuates
neointima formation. Mol. Ther. 16, 1798–1804.
Kuhnert, F., Mancuso, M.R., Shamloo, A., Wang, H.T., Choksi, V., Florek, M.,
Su, H., Fruttiger, M., Young, W.L., Heilshorn, S.C., and Kuo, C.J. (2010).
Essential regulation of CNS angiogenesis by the orphan G protein-coupled re-
ceptor GPR124. Science 330, 985–989.
Lambert, E., Coissieux, M.M., Laudet, V., and Mehlen, P. (2012). Netrin-4 acts
as a pro-angiogenic factor during zebrafish development. J. Biol. Chem. 287,
3987–3999.
Lamont, R.E., Lamont, E.J., and Childs, S.J. (2009). Antagonistic interactions
among Plexins regulate the timing of intersegmental vessel formation. Dev.
Biol. 331, 199–209.
Larrieu-Lahargue, F., Welm, A.L., Thomas, K.R., and Li, D.Y. (2010). Netrin-4
induces lymphangiogenesis in vivo. Blood 115, 5418–5426.
Larrieu-Lahargue, F., Welm, A.L., Thomas, K.R., and Li, D.Y. (2011). Netrin-4
activates endothelial integrin alpha6beta1. Circ. Res. 109, 770–774.
Larrieu-Lahargue, F., Thomas, K.R., and Li, D.Y. (2012). Netrin ligands and re-
ceptors: lessons from neurons to the endothelium. Trends Cardiovasc. Med.
22, 44–47.
Larrive´e, B., Freitas, C., Trombe, M., Lv, X., Delafarge, B., Yuan, L., Bouvre´e,
K., Bre´ant, C., Del Toro, R., Bre´chot, N., et al. (2007). Activation of the UNC5B
receptor by Netrin-1 inhibits sprouting angiogenesis. Genes Dev. 21, 2433–
2447.
Larrive´e, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A.,
Simons, M., and Eichmann, A. (2012). ALK1 signaling inhibits angiogenesis
by cooperating with the Notch pathway. Dev. Cell 22, 489–500.
Lejmi, E., Leconte, L., Pe´dron-Mazoyer, S., Ropert, S., Raoul, W., Lavalette, S.,
Bouras, I., Feron, J.G., Maitre-Boube, M., Assayag, F., et al. (2008). Netrin-4
inhibits angiogenesis via binding to neogenin and recruitment of Unc5B.
Proc. Natl. Acad. Sci. USA 105, 12491–12496.
Lenard, A., Ellertsdottir, E., Herwig, L., Krudewig, A., Sauteur, L., Belting, H.G.,
and Affolter, M. (2013). In vivo analysis reveals a highly stereotypic morphoge-
netic pathway of vascular anastomosis. Dev. Cell 25, 492–506.Neuron 87, July 15, 2015 ª2015 Elsevier Inc. 293
Neuron
ReviewLi, W., Kohara, H., Uchida, Y., James, J.M., Soneji, K., Cronshaw, D.G., Zou,
Y.R., Nagasawa, T., and Mukouyama, Y.S. (2013). Peripheral nerve-derived
CXCL12 and VEGF-A regulate the patterning of arterial vessel branching in
developing limb skin. Dev. Cell 24, 359–371.
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C.J.,
Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008). Wnt/beta-catenin
signaling controls development of the blood-brain barrier. J. Cell Biol. 183,
409–417.
Lim, A.H., Suli, A., Yaniv, K., Weinstein, B., Li, D.Y., and Chien, C.B. (2011).
Motoneurons are essential for vascular pathfinding. Development 138,
3847–3857.
Liu, G., Beggs, H., Ju¨rgensen, C., Park, H.T., Tang, H., Gorski, J., Jones, K.R.,
Reichardt, L.F., Wu, J., and Rao, Y. (2004). Netrin requires focal adhesion ki-
nase and Src family kinases for axon outgrowth and attraction. Nat. Neurosci.
7, 1222–1232.
Lowery, L.A., and Van Vactor, D. (2009). The trip of the tip: understanding the
growth cone machinery. Nat. Rev. Mol. Cell Biol. 10, 332–343.
Lu, X., Le Noble, F., Yuan, L., Jiang, Q., De Lafarge, B., Sugiyama, D., Bre´ant,
C., Claes, F., De Smet, F., Thomas, J.L., et al. (2004). The netrin receptor
UNC5B mediates guidance events controlling morphogenesis of the vascular
system. Nature 432, 179–186.
Luhmann, U.F., Meunier, D., Shi, W., Lu¨ttges, A., Pfarrer, C., Fundele, R., and
Berger, W. (2005). Fetal loss in homozygous mutant Norrie disease mice: a
new role of Norrin in reproduction. Genesis 42, 253–262.
Mackenzie, F., and Ruhrberg, C. (2012). Diverse roles for VEGF-A in the ner-
vous system. Development 139, 1371–1380.
Makita, T., Sucov, H.M., Gariepy, C.E., Yanagisawa, M., and Ginty, D.D.
(2008). Endothelins are vascular-derived axonal guidance cues for developing
sympathetic neurons. Nature 452, 759–763.
Mammoto, A., Connor, K.M., Mammoto, T., Yung, C.W., Huh, D., Aderman,
C.M., Mostoslavsky, G., Smith, L.E., and Ingber, D.E. (2009). A mechanosen-
sitive transcriptional mechanism that controls angiogenesis. Nature 457,
1103–1108.
Mancuso, M.R., Kuhnert, F., and Kuo, C.J. (2008). Developmental angiogen-
esis of the central nervous system. Lymphat. Res. Biol. 6, 173–180.
Marin-Padilla, M. (1985). Early vascularization of the embryonic cerebral cor-
tex: Golgi and electron microscopic studies. J. Comp. Neurol. 241, 237–249.
Miao, R.Q., Gao, Y., Harrison, K.D., Prendergast, J., Acevedo, L.M., Yu, J., Hu,
F., Strittmatter, S.M., and Sessa, W.C. (2006). Identification of a receptor
necessary for Nogo-B stimulated chemotaxis andmorphogenesis of endothe-
lial cells. Proc. Natl. Acad. Sci. USA 103, 10997–11002.
Miao, R.Q., Fontana, J., Fulton, D., Lin, M.I., Harrison, K.D., and Sessa, W.C.
(2008). Dominant-negative Hsp90 reduces VEGF-stimulated nitric oxide
release and migration in endothelial cells. Arterioscler. Thromb. Vasc. Biol.
28, 105–111.
Moore, S.W., Biais, N., and Sheetz, M.P. (2009). Traction on immobilized
netrin-1 is sufficient to reorient axons. Science 325, 166.
Morote-Garcia, J.C., Napiwotzky, D., Ko¨hler, D., and Rosenberger, P. (2012).
Endothelial Semaphorin 7A promotes neutrophil migration during hypoxia.
Proc. Natl. Acad. Sci. USA 109, 14146–14151.
Moya, I.M., Umans, L., Maas, E., Pereira, P.N., Beets, K., Francis, A., Sents,
W., Robertson, E.J., Mummery, C.L., Huylebroeck, D., and Zwijsen, A.
(2012). Stalk cell phenotype depends on integration of Notch and Smad1/5
signaling cascades. Dev. Cell 22, 501–514.
Nacht, M., St Martin, T.B., Byrne, A., Klinger, K.W., Teicher, B.A., Madden,
S.L., and Jiang, Y. (2009). Netrin-4 regulates angiogenic responses and tumor
cell growth. Exp. Cell Res. 315, 784–794.
Nagase, T., Nagase, M., Machida, M., and Fujita, T. (2008). Hedgehog signal-
ling in vascular development. Angiogenesis 11, 71–77.
Navankasattusas, S., Whitehead, K.J., Suli, A., Sorensen, L.K., Lim, A.H.,
Zhao, J., Park, K.W., Wythe, J.D., Thomas, K.R., Chien, C.B., and Li, D.Y.294 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.(2008). The netrin receptor UNC5B promotes angiogenesis in specific vascular
beds. Development 135, 659–667.
Nikolaev, A., McLaughlin, T., O’Leary, D.D., and Tessier-Lavigne, M. (2009).
APP binds DR6 to trigger axon pruning and neuron death via distinct caspases.
Nature 457, 981–989.
Niswander, L. (2003). Pattern formation: old models out on a limb. Nat. Rev.
Genet. 4, 133–143.
Nolan, D.J., Ginsberg, M., Israely, E., Palikuqi, B., Poulos, M.G., James, D.,
Ding, B.S., Schachterle, W., Liu, Y., Rosenwaks, Z., et al. (2013). Molecular sig-
natures of tissue-specificmicrovascular endothelial cell heterogeneity in organ
maintenance and regeneration. Dev. Cell 26, 204–219.
Nourshargh, S., Hordijk, P.L., and Sixt, M. (2010). Breaching multiple barriers:
leukocytemotility through venular walls and the interstitium. Nat. Rev.Mol. Cell
Biol. 11, 366–378.
Oertle, T., van der Haar, M.E., Bandtlow, C.E., Robeva, A., Burfeind, P., Buss,
A., Huber, A.B., Simonen, M., Schnell, L., Bro¨samle, C., et al. (2003). Nogo-A
inhibits neurite outgrowth and cell spreading with three discrete regions.
J. Neurosci. 23, 5393–5406.
Ogunshola, O.O., Stewart, W.B., Mihalcik, V., Solli, T., Madri, J.A., and Ment,
L.R. (2000). Neuronal VEGF expression correlates with angiogenesis in post-
natal developing rat brain. Brain Res. Dev. Brain Res. 119, 139–153.
Pan, Q., Chanthery, Y., Liang, W.C., Stawicki, S., Mak, J., Rathore, N., Tong,
R.K., Kowalski, J., Yee, S.F., Pacheco, G., et al. (2007). Blocking neuropilin-1
function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer
Cell 11, 53–67.
Park, K.W., Crouse, D., Lee, M., Karnik, S.K., Sorensen, L.K., Murphy, K.J.,
Kuo, C.J., and Li, D.Y. (2004). The axonal attractant Netrin-1 is an angiogenic
factor. Proc. Natl. Acad. Sci. USA 101, 16210–16215.
Phng, L.K., Potente, M., Leslie, J.D., Babbage, J., Nyqvist, D., Lobov, I., Ondr,
J.K., Rao, S., Lang, R.A., Thurston, G., and Gerhardt, H. (2009). Nrarp coordi-
nates endothelial Notch and Wnt signaling to control vessel density in angio-
genesis. Dev. Cell 16, 70–82.
Phng, L.K., Stanchi, F., and Gerhardt, H. (2013). Filopodia are dispensable for
endothelial tip cell guidance. Development 140, 4031–4040.
Pitulescu, M.E., Schmidt, I., Benedito, R., and Adams, R.H. (2010). Inducible
gene targeting in the neonatal vasculature and analysis of retinal angiogenesis
in mice. Nat. Protoc. 5, 1518–1534.
Pola, R., Ling, L.E., Silver, M., Corbley, M.J., Kearney, M., Blake Pepinsky, R.,
Shapiro, R., Taylor, F.R., Baker, D.P., Asahara, T., and Isner, J.M. (2001). The
morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two
families of angiogenic growth factors. Nat. Med. 7, 706–711.
Potente, M., Gerhardt, H., and Carmeliet, P. (2011). Basic and therapeutic as-
pects of angiogenesis. Cell 146, 873–887.
Powell, A.W., Sassa, T., Wu, Y., Tessier-Lavigne, M., and Polleux, F. (2008).
Topography of thalamic projections requires attractive and repulsive functions
of Netrin-1 in the ventral telencephalon. PLoS Biol. 6, e116.
Quaegebeur, A., Lange, C., and Carmeliet, P. (2011). The neurovascular link in
health and disease: molecular mechanisms and therapeutic implications.
Neuron 71, 406–424.
Rehm, H.L., Zhang, D.S., Brown, M.C., Burgess, B., Halpin, C., Berger, W.,
Morton, C.C., Corey, D.P., and Chen, Z.Y. (2002). Vascular defects and senso-
rineural deafness in a mouse model of Norrie disease. J. Neurosci. 22, 4286–
4292.
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T.,
Maira, G., Parati, E.A., Stassi, G., Larocca, L.M., and De Maria, R. (2010).
Tumour vascularization via endothelial differentiation of glioblastoma stem-
like cells. Nature 468, 824–828.
Rocha, S.F., and Adams, R.H. (2009). Molecular differentiation and specializa-
tion of vascular beds. Angiogenesis 12, 139–147.
Ruhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa,
H., Betsholtz, C., and Shima, D.T. (2002). Spatially restricted patterning cues
Neuron
Reviewprovided by heparin-binding VEGF-A control blood vessel branching morpho-
genesis. Genes Dev. 16, 2684–2698.
Runkle, E.A., and Antonetti, D.A. (2011). The blood-retinal barrier: structure
and functional significance. Methods Mol. Biol. 686, 133–148.
Sawamiphak, S., Ritter, M., and Acker-Palmer, A. (2010a). Preparation of
retinal explant cultures to study ex vivo tip endothelial cell responses. Nat.
Protoc. 5, 1659–1665.
Sawamiphak, S., Seidel, S., Essmann, C.L., Wilkinson, G.A., Pitulescu, M.E.,
Acker, T., and Acker-Palmer, A. (2010b). Ephrin-B2 regulates VEGFR2 function
in developmental and tumour angiogenesis. Nature 465, 487–491.
Schwab, M.E. (2010). Functions of Nogo proteins and their receptors in the
nervous system. Nat. Rev. Neurosci. 11, 799–811.
Segura, I., De Smet, F., Hohensinner, P.J., Ruiz de Almodovar, C., and Carme-
liet, P. (2009). The neurovascular link in health and disease: an update. Trends
Mol. Med. 15, 439–451.
Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari,
F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., et al. (2003). Class 3
semaphorins control vascular morphogenesis by inhibiting integrin function.
Nature 424, 391–397.
Soker, S., Takashima, S., Miao, H.Q., Neufeld, G., and Klagsbrun, M. (1998).
Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-spe-
cific receptor for vascular endothelial growth factor. Cell 92, 735–745.
Stenman, J.M., Rajagopal, J., Carroll, T.J., Ishibashi, M., McMahon, J., and
McMahon, A.P. (2008). Canonical Wnt signaling regulates organ-specific as-
sembly and differentiation of CNS vasculature. Science 322, 1247–1250.
Stenzel, D., Franco, C.A., Estrach, S., Mettouchi, A., Sauvaget, D., Rosewell, I.,
Schertel, A., Armer, H., Domogatskaya, A., Rodin, S., et al. (2011). Endothelial
basement membrane limits tip cell formation by inducing Dll4/Notch signalling
in vivo. EMBO Rep. 12, 1135–1143.
Stewart, P.A., and Wiley, M.J. (1981). Developing nervous tissue induces for-
mation of blood-brain barrier characteristics in invading endothelial cells: a
study using quail—chick transplantation chimeras. Dev. Biol. 84, 183–192.
Stone, J., Itin, A., Alon, T., Pe’er, J., Gnessin, H., Chan-Ling, T., and Keshet, E.
(1995). Development of retinal vasculature is mediated by hypoxia-induced
vascular endothelial growth factor (VEGF) expression by neuroglia. J. Neuro-
sci. 15, 4738–4747.
Storkebaum, E., Quaegebeur, A., Vikkula, M., and Carmeliet, P. (2011). Cere-
brovascular disorders: molecular insights and therapeutic opportunities. Nat.
Neurosci. 14, 1390–1397.
Sultana, H., Neelakanta, G., Foellmer, H.G., Montgomery, R.R., Anderson,
J.F., Koski, R.A., Medzhitov, R.M., and Fikrig, E. (2012). Semaphorin 7A con-
tributes to West Nile virus pathogenesis through TGF-b1/Smad6 signaling.
J. Immunol. 189, 3150–3158.
Tam, S.J., and Watts, R.J. (2010). Connecting vascular and nervous system
development: angiogenesis and the blood-brain barrier. Annu. Rev. Neurosci.
33, 379–408.
Tam, S.J., Richmond, D.L., Kaminker, J.S., Modrusan, Z., Martin-McNulty, B.,
Cao, T.C., Weimer, R.M., Carano, R.A., van Bruggen, N., and Watts, R.J.
(2012). Death receptors DR6 and TROY regulate brain vascular development.
Dev. Cell 22, 403–417.
Tavazoie, M., Van der Veken, L., Silva-Vargas, V., Louissaint, M., Colonna, L.,
Zaidi, B., Garcia-Verdugo, J.M., and Doetsch, F. (2008). A specialized vascular
niche for adult neural stem cells. Cell Stem Cell 3, 279–288.
Torres-Va´zquez, J., Gitler, A.D., Fraser, S.D., Berk, J.D., Fishman, M.C.,
Childs, S., Epstein, J.A., and Weinstein, B.M.; Van N Pham (2004). Sema-
phorin-plexin signaling guides patterning of the developing vasculature. Dev.
Cell 7, 117–123.
Toyofuku, T., Zhang, H., Kumanogoh, A., Takegahara, N., Suto, F., Kamei, J.,
Aoki, K., Yabuki, M., Hori, M., Fujisawa, H., and Kikutani, H. (2004). Dual roles
of Sema6D in cardiac morphogenesis through region-specific association of
its receptor, Plexin-A1, with off-track and vascular endothelial growth factor
receptor type 2. Genes Dev. 18, 435–447.Toyofuku, T., Yabuki, M., Kamei, J., Kamei, M., Makino, N., Kumanogoh, A.,
and Hori, M. (2007). Semaphorin-4A, an activator for T-cell-mediated immu-
nity, suppresses angiogenesis via Plexin-D1. EMBO J. 26, 1373–1384.
Uchida, C., Gee, E., Ispanovic, E., and Haas, T.L. (2008). JNK as a positive
regulator of angiogenic potential in endothelial cells. Cell Biol. Int. 32, 769–776.
Vasudevan, A., Long, J.E., Crandall, J.E., Rubenstein, J.L., and Bhide, P.G.
(2008). Compartment-specific transcription factors orchestrate angiogenesis
gradients in the embryonic brain. Nat. Neurosci. 11, 429–439.
Vieira, J.M., Schwarz, Q., and Ruhrberg, C. (2007). Selective requirements for
NRP1 ligands during neurovascular patterning. Development 134, 1833–1843.
Wacker, A., and Gerhardt, H. (2011). Endothelial development taking shape.
Curr. Opin. Cell Biol. 23, 676–685.
Wa¨lchli, T., Pernet, V., Weinmann, O., Shiu, J.Y., Guzik-Kornacka, A., Decrey,
G., Yu¨ksel, D., Schneider, H., Vogel, J., Ingber, D.E., et al. (2013). Nogo-A is a
negative regulator of CNS angiogenesis. Proc. Natl. Acad. Sci. USA 110,
E1943–E1952.
Wa¨lchli, T., Mateos, J.M., Weinman, O., Babic, D., Regli, L., Hoerstrup, S.P.,
Gerhardt, H., Schwab, M.E., and Vogel, J. (2015). Quantitative assessment
of angiogenesis, perfused blood vessels and endothelial tip cells in the post-
natal mouse brain. Nat. Protoc. 10, 53–74.
Wang, H.U., Chen, Z.F., and Anderson, D.J. (1998). Molecular distinction and
angiogenic interaction between embryonic arteries and veins revealed by
ephrin-B2 and its receptor Eph-B4. Cell 93, 741–753.
Wang, B., Xiao, Y., Ding, B.B., Zhang, N., Yuan, Xb., Gui, L., Qian, K.X., Duan,
S., Chen, Z., Rao, Y., and Geng, J.G. (2003). Induction of tumor angiogenesis
by Slit-Robo signaling and inhibition of cancer growth by blocking Robo activ-
ity. Cancer Cell 4, 19–29.
Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K.E., Geber, A.,
Fligelman, B., Leversha, M., Brennan, C., and Tabar, V. (2010a). Glioblastoma
stem-like cells give rise to tumour endothelium. Nature 468, 829–833.
Wang, Y., Nakayama, M., Pitulescu, M.E., Schmidt, T.S., Bochenek, M.L.,
Sakakibara, A., Adams, S., Davy, A., Deutsch, U., Lu¨thi, U., et al. (2010b).
Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Nature 465, 483–486.
Wang, Y., Rattner, A., Zhou, Y., Williams, J., Smallwood, P.M., and Nathans, J.
(2012). Norrin/Frizzled4 signaling in retinal vascular development and blood
brain barrier plasticity. Cell 151, 1332–1344.
Weerasuriya, A., and Mizisin, A.P. (2011). The blood-nerve barrier: structure
and functional significance. Methods Mol. Biol. 686, 149–173.
Wei, Y.T., He, Y., Xu, C.L., Wang, Y., Liu, B.F., Wang, X.M., Sun, X.D., Cui, F.Z.,
and Xu, Q.Y. (2010). Hyaluronic acid hydrogel modified with nogo-66 receptor
antibody and poly-L-lysine to promote axon regrowth after spinal cord injury.
J. Biomed. Mater. Res. B Appl. Biomater. 95, 110–117.
Weis, S.M., and Cheresh, D.A. (2011). Tumor angiogenesis: molecular path-
ways and therapeutic targets. Nat. Med. 17, 1359–1370.
Whiteus, C., Freitas, C., and Grutzendler, J. (2014). Perturbed neural activity
disrupts cerebral angiogenesis during a postnatal critical period. Nature 505,
407–411.
Wilson, B.D., Ii, M., Park, K.W., Suli, A., Sorensen, L.K., Larrieu-Lahargue, F.,
Urness, L.D., Suh,W., Asai, J., Kock, G.A., et al. (2006). Netrins promote devel-
opmental and therapeutic angiogenesis. Science 313, 640–644.
Wong, H.K., Shimizu, A., Kirkpatrick, N.D., Garkavtsev, I., Chan, A.W., di Tom-
aso, E., Klagsbrun, M., and Jain, R.K. (2012). Merlin/NF2 regulates angiogen-
esis in schwannomas through a Rac1/semaphorin 3F-dependent mechanism.
Neoplasia 14, 84–94.
Xu, Q., Wang, Y., Dabdoub, A., Smallwood, P.M., Williams, J., Woods, C., Kel-
ley, M.W., Jiang, L., Tasman, W., Zhang, K., and Nathans, J. (2004). Vascular
development in the retina and inner ear: control by Norrin and Frizzled-4, a
high-affinity ligand-receptor pair. Cell 116, 883–895.
Ye, X., Wang, Y., Cahill, H., Yu, M., Badea, T.C., Smallwood, P.M., Peachey,
N.S., andNathans, J. (2009). Norrin, frizzled-4, and Lrp5 signaling in endothelial
cells controls a genetic program for retinal vascularization. Cell 139, 285–298.Neuron 87, July 15, 2015 ª2015 Elsevier Inc. 295
Neuron
ReviewYe, X., Wang, Y., and Nathans, J. (2010). The Norrin/Frizzled4 signaling
pathway in retinal vascular development and disease. Trends Mol. Med. 16,
417–425.
Yin, Y., Sanes, J.R., and Miner, J.H. (2000). Identification and expression of
mouse netrin-4. Mech. Dev. 96, 115–119.
Yu, J., Ferna´ndez-Hernando, C., Suarez, Y., Schleicher, M., Hao, Z., Wright,
P.L., DiLorenzo, A., Kyriakides, T.R., and Sessa, W.C. (2009). Reticulon 4B
(Nogo-B) is necessary for macrophage infiltration and tissue repair. Proc.
Natl. Acad. Sci. USA 106, 17511–17516.
Zacchigna, S., Lambrechts, D., and Carmeliet, P. (2008). Neurovascular sig-
nalling defects in neurodegeneration. Nat. Rev. Neurosci. 9, 169–181.296 Neuron 87, July 15, 2015 ª2015 Elsevier Inc.Zhao, B., Chun, C., Liu, Z., Horswill, M.A., Pramanik, K., Wilkinson, G.A., Ram-
chandran, R., and Miao, R.Q. (2010). Nogo-B receptor is essential for angio-
genesis in zebrafish via Akt pathway. Blood 116, 5423–5433.
Zlokovic, B.V. (2008). The blood-brain barrier in health and chronic neurode-
generative disorders. Neuron 57, 178–201.
Zlokovic, B.V. (2011). Neurovascular pathways to neurodegeneration in
Alzheimer’s disease and other disorders. Nat. Rev. Neurosci. 12, 723–738.
Zygmunt, T., Gay, C.M., Blondelle, J., Singh, M.K., Flaherty, K.M., Means,
P.C., Herwig, L., Krudewig, A., Belting, H.G., Affolter, M., et al. (2011). Sema-
phorin-PlexinD1 signaling limits angiogenic potential via the VEGF decoy re-
ceptor sFlt1. Dev. Cell 21, 301–314.
